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ABSTRACT 
 
Traditional methods of measuring oxygen saturation, e.g. pulse oximetry, depend on 
an adequate peripheral circulation and have a 20–30 second lag time before readings 
are obtained. This was a series of evaluations of novel optical probes, designed to 
measure oxygen saturation using fibreoptic technology directly from internal organs 
including the brain, oesophagus and organs with splanchnic circulations. A series of 
pilot studies were proposed and research ethics approval obtained to carry out 
studies in humans, under general anaesthesia, using these probes. Innovative 
reflectance probes were designed specifically for each of the four applications, so as 
to obtain potentially useful signals needed for signal processing, analysis and 
evaluation. 
 
Signals were successfully obtained from the brain, oesophagus and splanchnic region 
in almost all of the patients recruited. Good quality photoplethysmograph signals 
were recorded and these were translated into clinically meaningful values of oxygen 
saturation comparable to traditional methods of pulse oximetry. Overall, the signals 
were prone to movement artefacts as well as occasional interference from surgical 
diathermy and other sources. Nonetheless, the probes could prove to be a useful 
alternative to conventional external transmittance pulse oximetry methods as well as 
providing useful information regarding regional perfusion and oxygenation. The 
success of these pilot studies will form the basis of more research in the area and 
further development of such probes on the medical engineering front. 
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CHAPTER ONE – INTRODUCTION 
 
As an anaesthetist, I am at the forefront of the usage of modern monitoring 
equipment for looking after the unconscious patient. Whether deliberate or not, as 
anaesthetists and clinicians, we are often presented with the opportunity to use the 
latest given technology to aid us in looking after our patients. This encompasses 
anything from the newest anaesthetic machines or ventilators available, to syringe 
pumps for titrating medications, or fibreoptic endoscopes for performing laryngeal 
intubations in patients with difficult airway anatomy. There are several questions 
which spring to mind when thinking about existing technology: namely, how we can 
improve what we already have; and the role of future devices developed in 
anaesthesia and surgery that could make a difference to clinical care.  
 
Oxygenation, and the ability to measure oxygen levels in the human body, 
accurately, speedily and with nil or minimal side effects, is key in many areas of 
medicine and surgery. It is assumed that well oxygenated tissue goes hand in hand 
with healthy viable organs as opposed to tissue that has been starved of oxygen. 
There are devices in the market already that measure global oxygenation in the body 
(pulse oximetry, CO-oximetry) but none really to measure specific end-organ 
oxygenation. Those devices in existence such as pulse oximetry, have changed 
medicine and surgery tremendously in the past twenty years, but also have their 
limitations (which will be discussed in detail in chapter two). In addition, global 
oxygenation does not necessarily indicate adequate regional oxygen supply and/or 
adequate perfusion of end organs in times of stress or illness. 
 
There is a clinical need, unmet by current commercially available technology, for 
measuring end-organ perfusion in the brain, kidney, bowel, when these structures are 
damaged in disease or trauma. For example, in patients who have sustained a head 
injury, and have intracranial monitoring in situ, a sustained rise in intracranial 
pressure (ICP) is a global indicator that things are not normal. If more information 
such as brain oxygen saturation could be obtained at the same time, it could influence 
the speed as well as strategy for intervention on that patient.  
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In order to make these ideas a reality, expertise was needed from engineers at City 
University with a research background in biomedical optics. In collaboration with 
this group, the challenge was to develop a set of devices that could have a distinct 
role to play in enhancing the current equipment we already have and/or to fulfil an 
area of unmet need using optics in the clinical setting. 
 
Probes and instrumentation were developed, capable of measuring tissue 
oxygenation in areas where traditional methods are not completely accurate, as well 
as in areas where this had not been done before. One of the main aims was to 
develop a device that could overcome some of the limitations shown in readily used 
monitoring equipment (e.g. pulse oximetry). Thus, much of the methodology 
involved comparison with traditional monitoring methods and the protocol for each 
study was written specifically with this in mind. 
 
Most physiological measurements are made using sensors, which measure a physical 
quantity (measurand) and converting it into a clinically useful variable using an 
appropriate algorithm. In this research the principal measurands were 
photoplethysmographic signals, from which oxygenation and perfusion may be 
derived.  Three distinct and novel monitoring sites were chosen, all of which are at 
risk of compromised perfusion in critically ill patients: the brain, the oesophagus and 
the abdominal organs. All three sites are difficult to access, so optical fibre sensors 
were a prerequisite for transmitting light to and from the tissue. 
 
The proposed research projects were a series of clinical evaluations of new optical 
methods of monitoring the oxygenation of blood within tissue, to achieve the above 
aims.  Fibreoptic probes were developed specifically for measurement from tissue 
sites within the body. Using essentially the same technology platform for different 
applications, probes were developed that allowed measurement of oxygen saturation 
in three different areas of the human body.  
 
The thesis is comprised of three main parts: measurement of oxygen saturation 
within brain tissue via a cranial bolt, measurement of oxygen saturation within the 
oesophagus, and finally measurement within the abdominal cavity. The measurement 
of oxygen saturation within the brain occurred in patients undergoing elective 
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neurosurgery, as well as in the patient with intracranial pathology. Measurements 
taken from the oesophagus and abdominal cavities were from that of anaesthetised 
patients undergoing elective surgery.  
 
As with any research project undertaken, full peer review, ethical approval along 
with medical physics testing and Medicines and Healthcare products Regulatory 
Agency (MHRA) were needed before the research was carried out in patients. I was 
the key investigator involved with preparing the protocol, idea development and 
design, along with obtaining full ethics approval. I was one of the main clinical 
recruiters of patients for the studies; and was the main liaison between the research 
and surgical teams whose patients we recruited for the studies. 
 
As a prelude to the three main studies–with pulse oximetry the common theme and 
impetus for this research–I will describe the history and evolution of pulse oximeters 
in chapter two.  The development of an innovative fibreoptic probe and the research 
that followed was to negate some of the limitations of classic pulse oximetry. In 
chapter three, I will describe the current management and monitoring of patients with 
intracranial pathology, the problems with current treatment and diagnosis, and the 
application of a new fibreoptic probe in research for monitoring oxygen saturation in 
patients with intracranial pathology. The chapters after that will contain the 
descriptions and findings of using this fibreoptic technology, in obtaining oxygen 
saturation readings from the oesophagus, and also from the abdominal cavity. 
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CHAPTER TWO – PULSE OXIMETRY 
 
2.1 Background and evolvement of pulse oximetry 
 
The balance between oxygen delivery and consumption in all human beings is the 
essence of survival. Though some organs in the body can rely on anaerobic 
metabolism to survive for a short period of time, others such as the brain or heart 
require a constant supply of oxygen for aerobic metabolism and are most sensitive to 
change, with a high risk of damage should the demand for oxygen exceed supply. (1) 
 
Oxygen is vital to the functioning of every cell in the human body. In the absence of 
oxygen for a prolonged period, cells will die. Pulse oximetry was developed in 1971 
by Aoyagi using the ratio of red to infrared light absorption of pulsating components 
at the measuring site.(2)(3) Pulse oximetry differentiates between the pulsatile 
component that is arterial blood and the venous capillary blood (smooth flowing).  It 
was commercialised in 1981 by BIOX/Ohmeda and in 1983 by Nellcor. Pulse 
oximetry was introduced into clinical practice in the United States of America when 
it was first brought into the operating department as a simple, non-invasive way of 
continuously being able to measure patients’ oxygen saturation. The introduction of 
commercially available pulse oximeters revolutionised the practice of anaesthesia 
and patient monitoring in healthcare settings across the world. In the United 
Kingdom as in many other countries, pulse oximetry is mandatory monitoring during 
every general anaesthetic. (4) 
 
Pulse oximetry is not only able to provide real-time monitoring of a patient’s oxygen 
saturation but is able give a continuous reading of heart rate. Over the years, the 
recognised advantages of this user friendly, relatively low cost device has given it an 
established niche in clinical practice. The probe is usually applied to the finger, but 
has been applied to other areas such as the ear and nose.  There are, however 
limitations to the use of pulse oximetry. Pulse oximetry is a measure of oxygenation 
only and not of ventilation. It gives no measure of carbon dioxide levels, blood 
electrolytes or blood pH. Pulse oximetry may also be inaccurate or fail in cases of 
hypoperfusion, peripheral vasoconstriction or motion artefacts. It can also be 
inaccurate in the presence highly calloused skin, low signal-to-noise ratio, abnormal 
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pulse rates, irregular rhythm, ventilator-induced and venous pulse interference, 
ambient light, electrosurgery, skin pigments/dyes/nail polish, burns and 
dysfunctional haemoglobins. As oximetry is simply based on colorimetric or  
spectrophotometric methods; a simple system (dual wavelengths) is unable to 
identify the presence of abnormal haemoglobins, and hence carboxyhaemoglobin 
(found in heavy smokers or in carbon monoxide poisoning from combustion 
products) which is cherry red will result in a falsely high reading, although the actual 
percentage of oxyhaemoglobin may be critically low. The presence of 
methaemoglobinaemia characteristically causes pulse oximeters to under read around 
85% saturation. Whilst pulse oximeters give an indication of the adequacy of 
oxygenation of arterial blood, it is not an indicator of organ tissue oxygenation and 
overall well-being.(5) 
 
2.2 How pulse oximeters work 
2.2.1 Photoplethysmography 
 
The photoplethysmograph (PPG) trace is derived from the change of attenuation of 
light energy transmitted or reflected through the tissues over which the pulse 
oximeter has been applied. (6) When the probe is attached to the fingertip or the 
earlobe, the pulsations detected are almost exclusively from the cutaneous vascular 
bed. Any factors that regulate blood flow of the skin will have a profound effect on 
the plethysmogram. The following are some factors that affect cutaneous blood flow: 
  
• Neurogenic factors: sympathetic vasoconstrictor fibres, cholinergic 
innervations to sweat glands resulting in vasodilation 
• Reflex vasoconstriction in skin: local /central cooling, hypotension, painful 
stimuli, fear, deep inspiration 
• Reflex vasodilatation in skin: heating, stimulation of chemoreceptors, 
coronary occlusion, acute hypertension 
• Humoral control: α-adrenergic, serotonin, prostaglandins, vasopressin, 
angiotensin, all causing vasoconstriction 
• Miscellaneous: systemic hypoxaemia/hypercapnia 
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Most commercially available pulse oximeters  feature a display of the real-time 
photoplethysmograph signal. The photoplethysmograph obtained by a pulse oximeter 
is obtained by shining light through the tissue and essentially measuring changes in 
the amount of light absorbed by the tissue. In addition, it is feasible to obtain a 
(reflectance) photoplethysmograph from light “reflected “ (actually re-emitted) by 
the tissue.  
 
2.3 Physical/optical principles 
 
Pulse oximetry is based on the Beer-Lambert law which states that for a beam of 
monochromatic radiation passing through a homogeneous solution, the absorbance is 
proportional to the product of the concentration and path length. A source of light 
originates from the probe at two wavelengths (650 nm and 805 nm). The light is 
partly absorbed by haemoglobin, by amounts which differ depending on whether it is 
saturated or desaturated with oxygen. By calculating the absorption at the two 
wavelengths the processor can compute the proportion of haemoglobin which is 
oxygenated.  
 
Commercial devices show a displayed trace on screen – composite of filtered signals 
giving a smoothed shape and amplitude trend of PPG to give an oxygen saturation 
reading. The concentration of an apparently transparent substance in solution may be 
measured spectrophotometrically. In a spectrophotometer, radiant energy is shone 
through a cuvette of known path length containing the substance being analysed. The 
energy source is usually a wide-bandwidth incandescent lamp, with a 
monochromator (e.g. prism, diffraction grating, or interference filters) in place to 
produce a single wavelength beam of energy. A proportion of the energy is absorbed 
by the solution under analysis. The Beer-Lambert law relates the fraction of radiant 
energy absorbed by the substance to the concentration and amount of the substance 
by the following formula: 
 
                                                 A= log(I0/I) = εlc                         (2.1) 
 
Where A is the absorbance of the sample and is proportional to the concentration (c) 
and the path length (l); and ε is the molar extinction coefficient in Equation (2.1), 
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which is a wavelength dependent constant characterising the sample. It is defined as 
the optical density of an absorbing substance in a concentration of 1 mmol/l 
measured with a light path length of 1 cm at a specific wavelength. I0 is the intensity 
of the energy without the sample, and I is the intensity with the sample. 
 
Oximetry by any spectrophotometric means relies on the change in absorption of 
electromagnetic energy with change in the percentage of oxygen bound to 
haemoglobin (Hb). Human haemoglobin has a molecular weight of around 64585 
Daltons and contains two pairs of polypeptide chains: the α- chains and the β- 
chains. Each polypeptide chain is combined with one haem group which has one 
atom of iron in the ferrous state and is able to bind reversibly with one molecule of 
oxygen. The quaternary structure of the four chains is of critical importance to pulse 
oximetry as the change in the shape of this quaternary structure with the degree of 
oxygenation alters the optical absorption spectrum proportionately and forms the 
basis of optical absorption oximetry.  Figure 2.1 shows the absorption spectra of 
haemoglobin. 
 
 
 
Figure 2.1 Absorption spectra of oxygenated and deoxygenated haemoglobin in the near-
ultraviolet to near-infrared range. Data from (7); Image reproduced from(8). 
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The pulse oximeter is dependant on a pulsatile flow and produces a graph of the 
quality of flow. Where flow is sluggish (e.g. hypovolaemia or vasoconstriction) the 
pulse oximeter may be unable to function. The computer within the oximeter is 
capable of distinguishing pulsatile flow from other more static signals (such as tissue 
or venous signals) to display only the arterial flow. Nearly all currently available 
conventional pulse oximeters make use of two wavelengths of light, usually 660 nm 
and 940 nm. The light is generated in the probe by a combination of light-emitting 
diodes with a miniature semiconductor photodetector, which is enclosed into a 
compact probe for attachment to the fingertip or earlobe. The probe is connected to 
the main unit via a small lightweight cable. The exception to this setup are the probes 
used in magnetic resonance imaging (MRI) scanner where all of the electronic 
components are in the main unit, and the light energy is transmitted to and from the 
patient by optical fibres. 
 
Conventional pulse oximeters function by comparing the absorption of energy at two 
wavelengths, usually 660 nm and 940 nm. A value, SpO2, is approximately equal to 
arterial haemoglobin saturation, SaO2, which is determined from the ratio of the 
absorption of the energy at the two wavelengths, by the pulsating blood component 
of the tissue (i.e. the arterial blood). The range of wavelengths over which 
spectrophotometric techniques can be used in vivo is limited to the range between 
600 and 1300 nm. At wavelengths less than 600 nm, melanin in skin causes a high 
level of absorption and at longer wavelengths of above 1300 nm, there is a stronger 
absorption due to the water content in the tissues. At the isobestic points, where the 
two lines cross each other on the graph, are the wavelengths at which the ε values of 
the two–oxygenated and deoxygenated haemoglobin are equal. The isobestic points 
can be used in combination with another wavelength with a large difference in 
absorption to correct for changes in intensity caused by factors such as probe 
placement. 
 
The light emitting diodes are placed in close contact with the skin surface. The light 
energy is detected with a semiconductor detector, placed on the skin perpendicularly 
opposite the diodes in the case of the transmittance pulse oximeters. A few pulse 
oximeters have the detector mounted adjacent to the light emitting diodes. In 
practice, the light absorption through the finger varies by about 1–2% of the total 
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absorption, partly due to haemoglobin content and path length changes in the cardiac 
cycle i.e. with the pulsatile expansion of the finger with each bolus of blood. The 
alignment of the erythrocytes also changes during different periods of the cardiac 
cycle, which contribute to the changes in absorption.  
 
The pulse oximeter is able to measure changes in absorption of light energy by oxy 
and deoxy-haemoglobin and is able to indicate the percent of haemoglobin which is 
oxygen saturated. Pulse oximeters perform spectrophotometry either by reflection 
from the skin or by transmission through an extremity; it is the latter that is the most 
commonly used method. The extremity e.g. the finger, needs to have a reasonably 
short optical path length to be sufficiently translucent at the wavelengths used, which 
are in the region of 600 nm to 1300 nm. Conventional pulse oximetry requires the 
use of one wavelength each side of the 805 nm isobestic point on the absorption 
spectra of adult haemoglobin. The Beer-Lambert law applies only for 
monochromatic radiation through a homogenous isotropic medium (one in which the 
refractive index is the same in all directions) with negligible scattering, where there 
is no association or dissociation of absorbing molecules. Light emitting diodes 
(LEDs), although strictly not monochromatic, can be used as a suitable energy 
source. With separate energy sources for each wavelength negating the need for 
narrow-bandwidth interference filters. LEDS can also be switched on and off very 
rapidly, as they do not have the thermal inertia of incandescent energy sources. Thus 
making it possible to use a single photodetector if the LEDs are used in this manner. 
 
A single photodetector is used to detect the energy alternately from both LEDs. In 
conventional transmission pulse oximetry, this is positioned perpendicularly opposite 
to the LEDs with the extremity held tightly between them. The flexible cable from 
the probe to the pulse oximeter unit carries the power to the LEDs and the signal 
from the photodetector. The main unit of the pulse oximeter contains electronic 
circuitry with functions listed below: 
 
• Amplification of the photodetector signal 
• Separation of the red and infrared plethysmograph signals 
• Switching and control of current through LEDs 
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• Adjustment of the gain of one of the two signals to make them equivalent 
• Analogue-to-digital conversion of the red and infrared signals 
• Reduction or elimination of artefacts 
• Calculation of the oxygen saturation (SpO2) 
• Display consisting of SpO2, plethysmogram and heart rate 
• Control of alarms 
• Storage of SpO2 trends 
 
2.4 Calibration of pulse oximeters 
 
The first pulse oximeters were calibrated based on the Beer-Lambert Law which 
applies only under conditions of non-turbidity, a single unknown solute and a fixed 
optical path length. Thus, empirical data is used for calibration instead. Until 
recently, calibration occurred in vivo by comparison with samples of arterial blood 
analysed with a haemoximeter, a laboratory instrument also known as a CO-
oximeter. Small samples of heparinised blood are haemolysed and passed into a 
transparent (often quartz) cuvette of fixed and known path length. This gives highly 
accurate readings of oxygen saturation at the time the blood is taken. It measures this 
using the principle of spectrophotometry, but using many more wavelengths of light 
than the two used in pulse oximetry. A wideband light source e.g. tungsten halogen 
lamp, is directed through the cuvette and the transmitted light passes through a 
monochromator which separates the light into its component wavelengths. 
 
Modern instruments measure the transmitted intensity of up to 128 separate 
wavelengths over a range of 500 nm to 700 nm using an array of photodiodes 
amplified, converted from a digital to analogue signal, and passed to a 
microprocessor, which calculates the oxygen saturation using numerical solutions to 
simultaneous equations based on selected wavelength measurements. The 
haemoximeter is also able to calculate the following values directly: oxy-
haemoglobin, carboxyhaemoglobin, methaemoglobin, “free haemoglobin”, sulph-
haemoglobin; and the following derived readings: total haemoglobin, fractional 
oxygen saturation, functional oxygen, oxygen capacity and oxygen content.  
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Since the blood is haemolysed, an effective haemoglobin solution is produced, so the 
Beer-Lambert law can be applied directly producing greater accuracy than in vivo 
methods. This is in contrast to pulse oximeters which must compensate for scattering 
effects within the tissue.  They are instead calibrated by the manufacturers using 
empirical data from volunteer studies as follows: probes were placed on the 
volunteers’ fingers, with them initially breathing air with enough oxygen to raise the 
arterial saturation to 100%. They then breathed an atmosphere of progressively less 
oxygen with proportionately more nitrogen. The atmosphere is made progressively 
more hypoxic in stages, each time allowing the volunteer to equilibrate at each new 
level of arterial saturation. When the pulse oximeter reads a steady saturation, 
samples of arterial blood are taken and tested in a CO-oximeter. A calibration curve 
of SpO2 versus SaO2 (true arterial oxygen saturation) can be plotted. There are 
obvious limitations to the level of oxygen desaturation ethically permissible in the 
healthy volunteer subjects, who desaturate by breathing progressively more hypoxic 
mixtures, due to the risk of hypoxic brain damage and/or injury associated with loss 
of consciousness. Also, because of this limitation, any values of SpO2 below 70% are 
extrapolated and thus not accurate. In addition, the position of the calibration points 
all closely spaced on the curve, leads to further inaccuracy in plotting.  
 
The development of an in vitro testing that can enhance accuracy and avoid the 
pitfalls of in vivo testing was necessary. Many devices, from the very simple to more 
complex have been developed to simulate artificial haemoglobin solutions and 
absorption. The advantages of in vitro calibration are the following: 
 
• Data points on the curve can be extended below 70% 
• Calibration studies are able to be repeated more readily 
• Safe in terms of subject’s morbidity 
• Effects of abnormal haemoglobins may be assessed easily 
• Standardisation of calibration 
• Effects of both physical and chemical interfering agents could be tested in 
a standardised fashion 
• Repeated calibration checks against the standard is possible 
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2.5 Medical applications and limitations of pulse oximetry 
 
Pulse oximetry provides an empirical measure of arterial saturation. It has become 
one of the minimal standards of monitoring in anaesthesia, critical care and in the 
post-operative recovery period. Pulse oximetry has probably been one of the greatest 
advances in patient monitoring in the past two decades. The ease of use, and ability 
to continuously monitor oxygen saturation by the bedside, in a non-invasive manner, 
has made it an acceptable, standard of monitoring in anaesthesia, in the post-
operative recovery room, on the critical care unit and on most medical wards. Due to 
its portable nature, it can also be found and used in ambulances and medical vehicles 
in the United Kingdom. 
 
The ability for pulse oximetry to detect changes in oxygen saturation has indeed 
cemented its place in routine clinical monitoring in anaesthesia and critical care, with 
beneficial outcome for patients and staff alike. A closed claim analysis concluded 
that the incidence of critical incidents due to airway accidents declined in the 1980s 
since the introduction of pulse oximetry.(9) This led to the American Society of 
Anaesthesiologists declaration of pulse oximetry to be one of the minimal standards 
of monitoring in anaesthesia in 1990. (10) 
 
The general correlation between SpO2 obtained by conventional pulse oximetry and 
actual arterial blood oxygen saturation is reasonably accurate–usually a less than 3 % 
discrepancy in readings provided the arterial oxygen saturation is above 70%. Whilst 
pulse oximetry is accepted as a non-invasive monitoring device that can fairly 
accurately detect hypoxemia in surgery, critical and anaesthesia; in cases where 
accuracy is paramount, such as detecting hyperoxia, the use of pulse oximetry is not 
so clear. (11) 
 
Critical incidents due to pulse oximeter errors are rare. The person using it must bear 
in mind its limitations and potentials for failure during its calibration period and 
application in clinical use. Oximeters are calibrated during manufacture and their 
internal circuits automatically checked when they are turned on. They are accurate in 
the range of oxygen saturations of 80 to 100% (±2%), but less accurate under 80%. 
The pitch of the audible pulse signal falls with reducing values of saturation. (12)(13) 
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The size of the pulse waveform is displayed graphically. In the clinical setting, the 
alarms on the machine ‘go off’ in response to changes in pulse rate beyond the set 
levels or oxygen saturation readings below 90%. This point suggests a marked 
deterioration of levels of oxygen in the blood, which could lead to serious problems 
if not rectified. While the response time of the pulse oximeter is generally fast, there 
can be quite a significant delay between a drop in arterial oxygen tension and a 
change in reading by the pulse oximeter. Delay in response is related to sensor 
location, with a quicker response when the sensor is placed more centrally. Factors 
affecting this delay or ‘lag time’ is influenced by poor peripheral perfusion due to 
hypothermia, peripheral vasoconstriction and motion artefacts. Drugs which can 
cause vasoconstriction such as adrenaline or vasospastic conditions such as 
Raynaud’s Syndrome can lead to a poor trace. Increasing the time over which the 
pulse signals are averaged can also increase the lag time. 
 
Figure 2.2 shows the oxygen dissociation curve, which illustrates the way in which 
oxygen is released to body tissues. The sigmoid shape of the curve shows how 
oxygen saturation is related to partial pressure of oxygen in the body. Haemoglobin’s 
affinity for oxygen increases the more molecules of oxygen bind to it. At pressures 
above 70 mmHg, the curve is rather flat, implying that the oxygen content of blood 
does not alter much despite large increases in oxygen partial pressure. The P50 also 
known as the partial pressure of oxygen in blood at which haemoglobin is 50% 
saturated, is around 26 mmHg, i.e. a measure of how much affinity haemoglobin has 
for oxygen. Disease, or other factors such as acidosis, or an increase in temperature 
or the presence of 2-3 DPG (diphosphoglyceric acid), shifts the curve to the right and 
hence changes the affinity of oxygen for haemoglobin. This is in order to allow the 
body more oxygen as required. Focusing on the steep part of the oxygen dissociation 
curve, the correlation between values obtained from SpO2 and actual oxygen content 
of blood is not linear, and any values below 90% is unreliable and must be 
considered to be a clinically meaningful change unless known otherwise. 
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Figure 2.2 Oxygen dissociation curve. Adapted from (14). 
 
Other reasons for unreliable readings include bright overhead lights in theatre; the 
signal may also be interrupted by surgical diathermy;(15) shivering may cause 
difficulties in picking up an adequate signal.(16) When methylene blue is used in 
surgery to the parathyroids or to treat methaemoglobinaemia, a short-lived reduction 
in saturation estimations is registered. (17) Nail varnish may cause falsely low 
readings. However the readings are not affected by jaundice, dark skin or 
anaemia.(18)(19)(20) 
 
Pulse oximeters from different manufacturers can also give different readings.(21) 
One reason for this is the differences used in calibration methods between different 
pulse oximeters and the variations in time it takes different monitors to detect a 
change in saturation. The manufacturing differences and errors in calibration or even 
the time over which the signals are averaged in a pulse oximeter, can lead to delays 
and problems during critical junctions of time when looking after a patient. It is 
therefore of utmost importance for the individual using this technology to be aware 
of the specifications and limitations of the equipment used in order to avoid any 
potential pitfalls. (22) In addition to its use in theatres and critical care areas, pulse 
oximetry is also used on wards for intermittent monitoring during routine bedside 
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observations, as well as in the transport of patients around the hospital, in the back of 
ambulances, and in medical clinics in the community due to its ease of use and 
portability. 
 
In recognition of the importance of the use of pulse oximetry in anaesthesia, the 2010 
standards for a safe practice of anaesthesia considers the use of pulse oximetry 
mandatory. The Association of Anaesthetists of Great Britain and Ireland (AAGBI) 
have taken a lead role in launching project LIFEBOX – saving lives through safer 
surgery; promoting and making pulse oximetry affordable and available to low-
resource countries, in order to make anaesthesia and surgery safer. (23) There is no 
doubt that judicious use of the pulse oximeter is of enormous benefit in terms of the 
early detection of hypoxia and will remain the minimal standard for monitoring 
under anaesthesia for years to come.  
 
2.6 New developments 
 
There are also now commercially available devices such as the Masimo Rainbow-
SET range of pulse oximeters that allow non-invasive measurement of haemoglobin 
concentration as well as the proportion of other haemoglobins such as 
methaemoglobin and carboxyhaemoglobin. (17)(22) The Masimo instruments give 
continuous readings of oxyhaemoglobin levels as well as oxygen saturation readings, 
oxygen content, and other haemoglobins, using multiple wavelengths of light. This 
allows the clinician additional information on oxygenation status in the patient. (24) 
A patient can appear well oxygenated, but still be hypoxic in the presence of carbon 
monoxide, as this binds to haemoglobin more avidly than oxygen does. Such a 
monitor, would allow us to be able to differentiate between such states. The other big 
advantage is that it allows bedside readings of other haemoglobins without the need 
for invasive and repeated blood sampling with quick results. (25) As these devices 
develop and increase in accuracy, there is likely to be an increase in consumer 
demand. 
 
The downside of any of these older as well as newer devices, is that while it may 
give an indication of oxygen saturation at any given time, it does not indicate how 
well a patient may be ventilating (i.e. carbon dioxide exchange) nor will it indicate a 
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problem when used intermittently in patients who are rousable when readings are 
taken, but could have a problem when left alone without continuous monitoring.  For 
example patients who have been given a dose of opioids or have sleep apnoea.  
 
Increasingly robust and reliable technology, has allowed more avenues for the 
application and research into the use of photoplethysmography (PPG) 
waveforms.(26) A greater study into the use of the PPG waveform remains, and with 
it the potential for its development into multimodal monitoring systems with the 
ability to measure and process more than one clinical variable at once.(27) This led 
to the development of what was essentially a fibreoptic probe; able to make use of 
PPG waveforms to obtain what we believe could be clinically useful results in a 
clinical setting. The next section describes the idea development and process making 
of this probe in detail.  
 
2.7 Development of fibreoptic probe 
 
Optical fibres are transparent rods of glass or plastic stretched so they are thin, long 
and flexible.(28)The instrumentation, developed jointly by the Pain and Anaesthesia 
Research Centre (Barts Health NHS Trust/QMUL) and the Department of 
Biomedical Engineering, City University London, utilises optical fibres to transmit 
light to, and receive reflected and re-emitted light from the tissue. 
 
The light-conducting principles behind optical fibres were first demonstrated in 
Victorian times, although modern optical fibres were only developed in the early 
1950s. Optical fibres became practical for use in communications in the late 1970s, 
once the attenuation was reduced sufficiently; since then, several technical advances 
have been made to improve the attenuation and dispersion properties of optical 
fibres, allowing signals to travel further and carry more information.  
 
Optical fibres have several uses in practice. They were first used in 
telecommunications because of the flexible properties, and that it could bundled 
together and travel over long distances. Fibres can be made of glass or plastic or a 
combination of the two. The extension of its use into medicine is due to the fact that 
optical fibres can be developed into sensors, capable of measuring many 
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physiological parameters. Variables such as temperature, blood flow, and oxygen 
levels can be detected and measured using optical sensors. It has also been 
incorporated in the use of surgical lasers, endoscopes and light sources for medical 
devices. The principle of operation is based on its cylindrical dielectric waveguide 
that allows the transmission of light along its axis, by the process of total internal 
reflection. The fibre consists of a core, surrounded by a cladding layer. To confine 
the optical signal in the core, the refractive index of the core must be greater than that 
of the cladding. 
 
An optical fibre can be operated in a great variety of physical configurations. 
Fibreoptics are involved in the transmission of light to and from the instrument and 
sensor. It is the use of light in the measurement that distinguishes fibreoptics from 
electrical sensors. (29) An optical fibre is usually made of glass or plastic. When 
glass is used for an optical fibre, it is unbelievably clear. It is designed to guide light 
along its length by confining as much light as possible in a propagating form. The 
glass fibre is capable of carrying light over varying distances. It does this by 
converting an input signal into short flashes of light, which travel down the fibre, and 
at the far end, are converted to an electrical signal by means of a photoelectric cell. 
 
The fibre is covered with a layer of glass (cladding) to avoid problems with 
contamination due to grease, dirt etc. The core and the cladding form a single solid 
fibre of glass. The optical fibre is very thin, usually a typical core size of 50 
micrometres. Unlike other forms of glass, the fibre is thin and flexible and can bend 
easily without shattering.  
 
Traditional methods of measuring oxygen saturation e.g. pulse oximetry depend on 
there being an adequate peripheral circulation and have a 20–30 second lag time 
before readings are obtained. With traditional pulse oximetry, values are measured 
around 600 times per second, an algorithm compares the measure values with stored 
values, then displays an averaged value over the previous five seconds. The design 
and build of the fibreoptic system in theory should not have this problem, and may 
give comparable results to traditional methods of oxygen saturation 
measurements.(4) It may also have the advantage of taking measurements from more 
central sites, thus negating the delay in taking measurements from the periphery. 
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The Biomedical Engineering Research Group based at City University, London, in 
collaboration with the Pain and Anaesthesia Research Centre at Barts Health NHS 
Trust, developed a system based on pulse oximeter technology, whereby oxygen 
saturation is measured by detecting photoplethysmographic (PPG) signals reflected 
from the tissues.(30) This system was built on the well-established principle of 
oximetry, a technique where light is used to determine the oxygen content of red 
blood cells by measuring the relative absorption of two wavelengths of light by 
haemoglobin in cells. Unlike current commercially available oximeters, which utilise 
external sensors, transmitting light through skin, bone and other tissue, the optical 
fibre system provides a means of directly accessing brain or oesophageal tissue etc. 
The system was built in an attempt to obtain rapid accurate regional measurement of 
organ tissue oxygen content.  In our studies, the raw signal data was displayed on the 
screen automatically.  All analysis was performed offline using a 10-second rolling 
window to calculate the SpO2 values etc. 
 
To date, non-invasive solutions have not succeeded fully in measuring tissue oxygen 
saturation. Our group has concentrated on developing probes that can be inserted into 
organs such as the brain and gullet. (31)(32)(33)The focus of this thesis will be the 
rationale for monitoring these organs, evaluation of tailor-made probes, and their 
potential application in clinical practice.  
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CHAPTER THREE – OXYGEN SATURATION MEASUREMENTS FROM 
BRAIN TISSUE IN NEUROSURGICAL AND INTENSIVE CARE PATIENTS  
 
3.1 Introduction and background 
Head injuries are a common cause of morbidity and mortality in trauma victims. 
Severe head injury accounts for more than 50% of trauma related deaths, most of 
which occur after road traffic accidents, falls and assaults.(34) Head injuries can be 
classified according to the degree of severity based upon the Glasgow Coma Scale 
(GCS) shown in Table 3.1. The Glasgow Coma Scale is a scale for measuring level 
of consciousness in which scoring is determined by three factors: amount of eye 
opening, verbal and motor responsiveness. It is a rough guide to predicting the 
duration and outcome of patients in a coma, primarily after suffering a head injury. 
The scale has a high degree of consistency, even when used by staff of varied 
experience. A GCS of less than 8 would suggest a deep or low level of 
unconsciousness whereas a score of 14 to15 would be the expected score in the alert, 
awake patient.   
3.2 Pathophysiology of head injury 
 
  Score 
Eye opening spontaneously 4 
 to speech 3 
 to pain 2 
 none 1 
   
Verbal response orientated 5 
 confused 4 
 inappropriate 3 
 incomprehensible 2 
 none 1 
   
Motor response obeys commands 6 
 localises to pain 5 
 withdraws from pain 4 
 flexion to pain 3 
 extension to pain 2 
 none 1 
   
Maximum score  15 
Table 3.1 Glasgow Coma Scale. 
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Primary brain injury results from the original insult, which occurred at the time of the 
injury. This unfortunately cannot be influenced by treatment. Injury at the time is due 
to deceleration forces of the brain within the skull, or lacerations from bony points 
inside the skull, shearing and rotational effects, and damage to blood vessels. These 
can be anything from intracranial haematomas (extradural, subdural or intracerebral) 
to diffuse axonal injury. Secondary brain injury occurs when cerebral oedema, 
ischaemia, infection or herniation exacerbates the original insult. Some of these can 
be prevented by correcting hypoxaemia, hypotension, hypercarbia, and by attention 
to other associated injuries.(35)(36) These secondary insults can cause permanent 
neurological damage and worsen outcome if left undetected and untreated.(37) 
 
3.3 Management of head injury 
 
The primary aim, after assessment of a trauma patient as stated in the standard 
Advanced Trauma Life Support (ATLS) protocol, is the prevention of the 
development of secondary brain injury. (38) This is done by optimising oxygenation 
of the patient and brain tissue perfusion. In particular, the normal autoregulation of 
cerebral blood flow may well be lost in a head injury, rendering the injured brain 
more susceptible to swings in blood pressure and hypoxia. (39)(40) Figure 3.1 
illustrates how cerebral blood flow is autoregulated. As blood pressure increases, 
cerebral blood flow is maintained at a constant until a critical point beyond which the 
brain will develop ischaemia and be prone to damage. (41) 
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Figure 3.1 Cerebral blood flow autoregulation curve. Reproduced from (42).  
 
The ATLS management of head injured patients relies on the Glasgow Coma Scale 
following resuscitation. Patients with a mild head injury (GCS 13 to 15) should be 
admitted to a hospital ward and regular neurological observations made and the 
appropriate action taken if there is a change in neurological status. All patients with a 
GCS of less than 13 should have a computerised tomography (CT) scan of their head. 
Those with severe head injuries will be intubated and ventilated and on full 
cardiorespiratory support in an intensive care unit with neurosurgical teams available 
should the patients need any sort of neurosurgical intervention. The decision to 
operate on a head injured patient is based on various factors in the history including 
the premorbid state and GCS at the scene of the accident (i.e. severity of injury), 
onset and rate of neurological compromise. These would be supported by 
radiological findings on accompanying CT scans. (43) 
 
The aim in the treatment of head injured patients is to maintain an adequate cerebral 
perfusion pressure, reduce intracranial pressure and cerebral oedema. This is aided in 
part by keeping physiological parameters as ideal as possible to aid in recovery e.g. 
normoglycaemia, nutritional and haemodynamic support; keeping normal or low 
carbon dioxide levels, temperature control, patient positioning to avoid venous 
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congestion and raising ICP. (44)The one purpose of brain monitoring, is to detect 
secondary insults and to be able to intervene early if appropriate. (45)(46)(47) 
 
3.4 Monitoring the brain 
3.4.1 Intracranial pressure  
 
Intracranial Pressure (ICP) is defined as the pressure within the rigid cranial cavity 
relative to atmospheric pressure.(48) Normal ICP ranges from 5-15mmHg in a 
resting healthy adult in the horizontal position. There is a vascular component as well 
as a cerebrospinal fluid (CSF) component.(49) It is pulsatile and reflects the cardiac 
and respiratory cycles.  An ICP of more than 15 mmHg is considered abnormal. 
There are different waveforms seen with an ICP trace (Table 3.2), with differing 
amplitudes and associations as illustrated. 
 
 
 Associated with Amplitude Duration 
A (plateau) waves Cerebral 
vasodilatation 
Reduced cerebral 
compliance 
50-200 mm Hg 5-20 min 
B waves Changes in 
respiratory pattern 
<50mm Hg 1 min 
C waves Blood pressure and 
systemic vasomotor 
tone 
<20 mmHg 7-15s 
 
Table 3.2 Different waveforms seen in an ICP trace. Adapted from (35). 
 
 
Figure 3.2 illustrates how cerebral blood flow is autoregulated. As blood pressure 
increases, cerebral blood flow is maintained at a constant until a critical point beyond 
which the brain will develop ischaemia and be prone to damage.  
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Figure 3.2 ICP-volume curve. Reproduced from (50). 
 
 
Prolonged rise in ICP is associated with a poor prognosis in head injured patients, 
and early treatment decreases mortality in these patients. In head injured patients, a 
rise in ICP of more than 20 mmHg usually demands treatment, depending on the 
underlying pathology, rate of deterioration and clinical circumstance. Thus a device 
for monitoring ICP is needed for such patients to detect any early changes in ICP that 
may need surgical intervention, for example, an enlarging haematoma that could be 
evacuated. 
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Measuring the ICP allows: 
1) Continuous monitoring of pressure changes within the cranium. Acute rises in ICP 
occur when the normal compensatory mechanisms fail. 
2) Analysis of the ICP waveform (Table 3.2): This provides information about 
transmission of the arterial pulse pressure through the arterial walls to the CSF space. 
As cerebral perfusion pressure (CPP) decreases, the wall tension in reactive brain 
vessels deceases as well, this in turn increases transmission of the arterial pulse to 
ICP. In normally reactive vessels, a decrease in CPP should invoke an increase in 
arterial blood pressure to ICP pulse transmission. 
• A (plateau) waves: amplitude 50–100mmHg, are usually most common in 
patients with intracranial tumours and represent severely reduced 
intracranial compliance. 
• B waves: amplitude <50mmHg, occur about one per minute, and 
associated with respiration. Less useful clinically. Variations of B waves 
called ‘ramp’ waves are seen in hydrocephalus 
• C waves: amplitude <20mmHg, about 4–8 occur per minute. These are 
related to systemic vasomotor tone and blood pressure and again not 
useful clinically. 
 
3) Estimation of cerebral perfusion pressure: CPP = MAP(mean arterial pressure)-
ICP. Thus increasing MAP raises CPP and raising ICP reduces it. The normal CPP is 
usually between 70–90mmHg in an adult. A lowering of CPP below 70 mmHg will 
lead to ischaemic brain damage. In the normal brain, CPP is maintained by 
autoregulation, within the limits of a MAP of 60–160mmHg. Autoregulation may be 
impaired by the head injured brain.(51) ICP is usually measured with devices placed 
in a ventricle, subdural space or directly into brain parenchyma. The various methods 
for monitoring will be listed and expanded on below: 
3.4.2 Intraventricular catheter 
 
The gold standard for ICP measurement is the intraventricular catheter, which is 
inserted into the lateral ventricle via a burr hole. It can be used to remove 
cerebrospinal fluid (CSF) and to give drugs e.g. antibiotics. It can be connected to an 
external pressure transducer. However, insertion maybe difficult in cases where there 
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is a lot of cerebral swelling. Infection rates are of the order of 1–5% and increases 
significantly with time. (52) 
3.4.3 Intraparenchymal monitors 
 
There are other ventricular, subdural or intraparenchymal microtransducers that can 
be inserted via a burr hole such as the Camino transducer, which makes use of a 
fibreoptic cable to direct light to a miniature displaceable mirror at the catheter tip, 
which is placed in brain tissue. ICP distorts this mirror and the reflected light 
intensity is transduced into pressure. Available also is a microchip Codman strain-
gauge sensor which can be inserted into the brain via a small burr hole, which 
converts resistance changes, due to ICP, into a voltage change.(53) These are deemed 
to be almost as accurate as ventricular drains and have relatively low rates of 
infection and bleeding. They are useful when the ventricles are inaccessible because 
of compression from raised ICP. The main disadvantages are that they cannot be 
recalibrated in vivo, and they measure localised pressure, which may not be an 
accurate reflection of ICP. CSF drainage is not possible, and they are subject to drift 
when used for prolonged periods. 
 
Subdural pressure transducers are the least invasive of the lot. The dura is pierced 
and the hollow device is filled with CSF; once equilibrium is reached, the pressure 
transduced is a reflection of ICP. However, this is not as accurate as the gold 
standard, and again CSF cannot be drained with this device and is subject to 
blockage and misplacement. It does possess a lower risk of infection and bleeding 
rate. 
 
3.4.4 Jugular bulb oximetry 
 
The jugular bulb, located in the internal jugular vein, just below the base of the skull, 
receives blood directly from the brain. Measuring the oxygen content of this blood 
allows the estimation of cerebral oxygen consumption. (54) 
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This involves inserting a retrograde catheter into the internal jugular vein and 
advancing it cephalad into the jugular bulb. Correct placement is confirmed by a 
lateral neck x-ray when the tip should be at the position of the mastoid air cells at the 
level of the first and second cervical vertebrae. The catheter contains a 
spectrophotometric fibreoptic probe and a lumen for aspiration of blood. Infrared 
light at three wavelengths measures haemoglobin concentration and oxygen 
saturations. Measurement of jugular venous oxygen saturation (SjvO2) can thus be 
made, and is normally of the range 60–75%. A value of less than 50% may indicate 
potential cerebral ischaemia. SjvO2 is dependant upon arterial oxygen saturation, 
cerebral blood flow and cerebral metabolic rate. It is used for the management of 
severe head injury, and is able to indicate how effective any intervention maybe, e.g. 
minimising the use of vasopressors to maintain an adequate CPP. (46)(55)  
 
Intermittent sampling will allow estimation of arteriovenous oxygen difference and 
lactate and give an indication of global cerebral oxygenation and metabolism. 
Continuous SjvO2 monitoring will detect episodes of desaturation associated with 
raised ICP e.g. hypotension, cerebral vasospasm, hyperventilation therapy. However, 
there is a false positive rate of up to 50%. It is also a measure of global cerebral 
oxygenation rather than regional oxygenation, and smaller areas of ischaemia could 
go undetected. The other limitations are the difficulties in obtaining accurate 
readings (due to difficulty in placement or too rapid an aspiration of the blood 
sample) and their interpretation. Inaccuracy can also result if the catheter is impacted 
against a vessel wall or if thrombosis occurs. Frequent calibration is also required 
and protein build-up at the catheter tip can lead to further inaccuracies.  As this 
monitor is invasive and can lead to local complications, current recommendations are 
that SjvO2 monitoring is used as a second-line device to help guide the treatment of 
raised ICP refractory to standard treatment. (56)(57) 
 
3.4.5 Transcranial Doppler ultrasonography 
 
Transcranial Doppler  is a non-invasive ultrasound based technique which measures 
blood velocity in the cerebral arterial system. A 2 MHz pulsed ultrasound signal is 
transmitted through the skull, usually via the temporal bone, to a depth of 5–6.5 cm. 
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The signal is reflected by the solid components of blood and is distorted according to 
the Doppler shift. The pulsatile waveform obtained is a reflection of the distal 
cerebral vascular resistance, providing there is no stenosis or vasospasm and that 
blood pressure remains constant. The main uses are: 
 
1. To differentiate between vasospasm and hyperaemia in patients with 
subarachnoid haemorrhage and brain injury. 
2. To determine the adequacy of collateral circulation during carotid surgery.  
3. Monitoring of patients who have had strokes; detection of micro emboli in 
the circulation. 
4. Estimation of perfusion pressure. 
 
In patients who have had a subarachnoid haemorrhage, the object of transcranial 
Doppler ultrasonography is to detect elevated flow velocities in the basal cerebral 
arteries suggesting vasospasm, and thus helping to identify patients at risk of 
developing delayed neurological effects. The transcranial Doppler is most reliable in 
detecting vasospasm of the middle cerebral artery. The reported positive predictive 
value is high (100%) whereas the negative predictive value is low (30%) when 
angiography is used as a reference standard. On the other hand, the positive 
predictive value is low (39%) whereas the negative predictive value is high (90%) 
when symptomatic vasospasm is used as a reference standard. Due to differences in 
anatomy and the lack of correlation between flow velocities and lumen diameter, and 
the presence of collateral blood flow, the transcranial Doppler is less reliable in 
detecting vasospasm in the major cerebral arteries apart from the middle cerebral 
artery. Blood flow and vessel diameter may be directly measured using the 
transcranial Doppler. The device is useful in deciding whether a clinical condition is 
deteriorating due to a result of vasospasm or if other causes should be excluded by 
performing a detailed CT scan. One of the major advantages is its ease of use by the 
bedside and its non-invasive nature allowing for repeated measurements. Its major 
limitations are that it is highly operator dependent and has no strong correlation 
between flow velocities measured and delayed neurological defects. (58)(59)  
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3.4.6 Near-infrared cerebral spectroscopy  
 
Near-infrared spectroscopy (NIRS) offers a non-invasive monitor of brain 
oxygenation. It is based on molecular overtones and combination variations. A 
sensor is placed on the patient’s forehead and shines infrared light (700–1000 nm) 
through the surface layers of the brain and the light that re-emerges is sensed by a 
dual detector system. The absorption of near infrared light is proportional to the 
concentration of certain chromophores, such as the iron in haemoglobin and copper 
in cytochrome aa3. Oxygenated haemoglobin, deoxygenated haemoglobin and 
cytochrome aa3 have different absorption spectra, depending on the patient’s 
oxygenation status. Changes in concentration of near infrared light as it goes through 
these compounds are quantified using the Beer-Lambert law, which describes optical 
attenuation. (60)(61) 
 
Instrumentation for NIRS is somewhat similar to instruments in the infrared and mid-
infrared range. There is a source and disperser (usually a prism or diffraction grating) 
to allow intensities of light of different wavelengths to be recorded. Common 
incandescent light bulbs are often used as light sources of near infrared radiation for 
analytical applications. The alternatives used are LEDs, which offer greater lifetime 
and spectral stability and are more energy efficient. 
 
The advantages of NIRS is that it is a non-invasive, non-ionising, pain-free means of 
estimating regional changes in cerebral oxygenation. (62) It is also able to estimate 
changes in cerebral blood volume. The monitor gives a real-time, display of cerebral 
oxygen levels and has been shown to correlate well with jugular bulb saturations in 
healthy volunteers under conditions of isocapnic hypoxia. The monitor is also highly 
portable (compared to MRI, see sub-section 3.4.10, and can be used in the infant 
population). Wireless instrumentation is also available which allows freedom of 
movement in the subjects being studied.  By injection of a dye, indocyanine green, 
cerebral blood flow and cerebral metabolic rate can be calculated. Due to its safe 
profile, NIRS can be used in paediatric intensive care units. (63) 
 
The disadvantages of NIRS is that the clinical use is limited by its inability to 
distinguish between intracranial and extracranial changes in blood flow and 
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oxygenation, with an effect on the accuracy of readings obtained. (64) It does 
remain, however, to be one of the established techniques for monitoring patients with 
head injury, is able to indicate cerebral hypoxia, and is available in most intensive 
care units that manage a large proportion of patients with head injuries. (65)Further 
studies are needed to establish its use in clinical practice. (66)(67)(68) 
 
3.4.7 Brain tissue oximetry 
 
There are two commercially available sensors to measure brain tissue oxygenation 
continuously. One device – Licox – measures only brain tissue oxygen tension 
(PbtO2) using a polarographic Clarke type electrode. The other – Neurotrend – is a 
multi-parameter sensor that can measure brain tissue oxygen, carbon dioxide and pH 
using fibreoptic technology. Both of these monitors can also measure brain 
temperature using a thermocouple. Both sensors are approximately 0.5 mm in 
diameter and can be inserted through a craniotomy intraoperatively or through a 
specifically designed bolt allowing insertion and fixation to the skull in the intensive 
care unit (ITU). (69)(70) 
 
The Licox monitor has played an important role in the implementation of multimodal 
monitoring in ITUs. The Licox system itself is supplied with a temperature, 
oxygenation and ICP probe – all three monitors are incorporated into one 
device.(71)The temperature probe is quoted to have an accuracy rate of up to 0.2 
degrees Celsius of the current temperature of any tissue up to five days in situ. It is 
also able to obtain precise PbtO2 values from regional areas of the brain and global 
ICP measurement.  
 
Accurate placement of Licox catheters is crucial to obtaining reliable readings. These 
are usually put in on the right side in the subarachnoid space of the frontal lobe with 
the oxygen probe extending into the white matter of the brain. A CT scan of the head 
can be used to locate the area of damage, and the catheter can be placed within the 
penumbra of the injury. The Licox may take up to 120 minutes to settle before 
readings can be obtained. To check the probe is working properly, an increase in 
inspired oxygen concentration in intubated patients should see a corresponding rise 
  39 
in value of PbtO2.  The values of PbtO2 vary greatly depending on placement of the 
Licox as well as insults during placement into brain tissue. Low readings may be due 
to microvascular compression of the probe within the area of injury. Placements in 
contusions, infarcts, and haemorrhagic areas may adversely affect oxygen 
measurements and may result in low readings of oxygen measurements. As a 
consequence, local placement may potentially lead to either over treatment or under 
treatment of viable brain tissue because of the limited information provided on 
surrounding areas. Likewise, placement of the probe in undamaged areas reflects 
changes in global oxygenation. PbtO2 readings are indicative and influenced by 
oxygen exchange within the capillary beds and by the diameter of the vessels that 
surround the catheter. After placement, the probe can take up to 80 minutes or more 
to adapt to brain tissue and to give accurate recordings. (48) 
 
The Licox is stable in brain tissue for up to 16 days, and recalibration is unnecessary. 
The Licox probe is contraindicated in coagulopathic states; the risk of infection or a 
contusion produced by the placement of a Licox monitor is less than 2%. The 
Neurotrend (Codman) system uses “optimal luminescence” to measure PbtO2. It also 
measures pH, tissue CO2 and temperature. It has a faster response time (compared to 
the Licox) to changes in oxygen concentration, and measured pH and PbtO2 
accurately. However, it is not as accurate as the Licox probe at lower oxygen 
concentrations and more prone to drift over time. (71) Brain oxygen oximetry is an 
invasive technique with the small risk of infection as a potential complication. The 
true diagnostic and prognostic value so far remains to be unreported with its impact 
on patient outcome undetermined. 
 
3.4.8 Microdialysis 
 
Cerebral microdialysis allows continuous online monitoring of changes in brain 
tissue chemistry. Most biochemical and metabolic events take place in the tissues,  
thus the function and pathophysiology of the brain is a reflection of changes in extra 
or intra- cellular molecular biology. Thus, being able to directly analyse tissue 
chemistry in the brain, could provide valuable data for patients with pathology of 
brain tissue. Microdialysis was first developed in the 1960s and has been changed 
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from a ‘bench to bedside’ technique. In microdialysis, a fine coaxial catheter 
(diameter 0.62 mm) is inserted into the brain. The catheter has a polyamide dialysis 
membrane on its outer surface and low flow rates (0.1–2.0 mcl/min) of dialysis fluid 
are passed through the catheter using a precision pump, allowing measurement of the 
concentration of chemicals in the cerebral extracellular fluid. Molecules below the 
size of about 20000 Daltons diffuse through the semi-permeable membrane which is 
collected into vials which are changed every 10 to 60 minutes. The collected 
dialysate is then analysed by sensitive assays. The main substances, which are of 
interest in the head injured patient, are: 
 
1. Energy related metabolites e.g. glucose, lactate, pyruvate, adenosine, 
xanthine. 
2. Neurotransmitters e.g. glutamate, aspartate, GABA (gamma-amino-butyric-
acid). 
3. Markers of tissue damage and inflammation e.g. glycerol, potassium, 
cytokines. 
4. Exogenous substances – administered drugs. 
 
Bedside equipment, allowing spectrophotometric analysis of chemicals of interest is 
commercially available. Cerebral microdialysis has been used in various other 
clinical scenarios, apart from head injured patients, such as subarachnoid 
haemorrhage, epilepsy, ischaemic stroke, tumours, and during neurosurgery. In 
severely head injured patients, deranged metabolism results in lower brain glucose 
and elevated lactate: pyruvate ratios during periods of intracranial hypertension and 
cerebral ischaemia. In patients with traumatic brain injury, any increases in lactate: 
pyruvate levels correlates with the severity of symptoms and clinical outcome. Wide 
variations in the concentration of glutamate and aspartate have been observed.  
 
Epileptic foci in the temporal lobe are associated with elevated glutamate and lower 
GABA levels prior to seizures and increases in both amino acids during seizures. If 
microdialysis catheters are implanted in relevant positions in relation to affected 
tissue, this technique can give prompt information on metabolism and its 
consequences for cell survival. One of the usefulness of this technique is that the 
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biochemical changes that are detected by intracerebral microdialysis appear before 
significant increases in intracranial pressure.(73) 
An evolving role of microdialysis is its use in measuring drug concentrations in brain 
tissue and the potential to be able to give drugs directly into specific areas. There are 
important limitations to the technique; one is that unless the microdialysis catheter is 
placed in the area where tissues are damaged, abnormal changes may not be detected. 
(74)(65) Whether the use of microdialysis, in clinical practice, will be routine is still 
not fully established.(75) 
 
3.4.9 Electrophysiology 
 
The electroencephalogram (EEG) is obtained from spontaneous electrical activity of 
the brain and is generated mainly by summation of excitatory and inhibitory post-
synaptic potentials of cortical neurones. The technique is non-invasive and the 
changes in EEG correlate closely with cerebral metabolism and ischaemia. The 
electrical trace is obtained from scalp electrodes placed at inter-electrode distances of 
either 10% or 20% of the head circumference, or inter-aural distance. The electrical 
signal is amplified, filtered and then displayed as either eight or sixteen graphs, with 
eight graphs per hemisphere, to give an accurate representation of the activity 
throughout the cortex. EEG is usually interpreted in terms of frequency (Table 3.3) 
amplitude and location. (48) 
 
 
Band Frequency Clinical State 
Delta <4 Hz Deep sleep, anaesthesia, cerebral ischaemia 
Theta 4-8 Hz Normal waves in premature infants/children in deep sleep 
Alpha 8-13 Hz Alert, relaxed individuals with eyes closed 
Beta >13 Hz Typically seen in alert awake adults and during light anaesthesia 
Table 3.3 EEG waveforms of the brain. Adapted from (35). 
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To enable continuous EEG monitoring, several automated processing systems are 
available: 
 
• Power spectral analysis allows rapid Fourier transformation of small 
intervals of EEG to give a graphical representation of the relative power 
content of the different frequency bands in each segment. The spectral 
analysis gives a single reading (e.g. mean frequency) which can be 
followed over time. 
• Cerebral Function Monitor (CFM) gives a single trace of total power 
varying with both amplitude and frequency of raw EEG data. 
• Cerebral Function Analysing Monitor (CFAM) which displays both 
amplitude and frequency and avoids the loss of information when these 
two variables are processed together. 
 
The EEG is most commonly used to investigate, diagnose and manage epilepsy as 
well as other conditions such as subacute sclerosing panencephalitis. It can also 
detect ischaemic cerebral insults, such as vasospasm and intracranial hypertension 
after head injury. Certain EEG features are associated with poor outcome in patients. 
Grade I and II are associated with a good outcome, grade III with an intermediate 
outcome, and grades IV and V are associated with a very poor outcome. (35) See 
Table 3.4 below. 
 
Grade I Dominant α , reactive 
Grade II Dominant θ-δ, reactive 
Grade III Dominant δ-θ, no α 
Grade IV Burst suppression low voltage δ, unreactive, 
periodic general phenomena 
Grade V Very low voltage EEG, isoelectric EEG 
Table 3.4 EEG interpretation.  
 
Although various EEG signal processing and display systems have been used   in 
routine monitoring of head injured patients during intensive care, they are not 
currently in widespread use. (73)(76)(77) The main limitations of this technique are 
the vulnerability to artefacts and reliance on trained neurophysiologists to interpret 
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results. Currently, EEG is used intermittently as a bedside diagnostic tool in patients 
with its true influence on patient outcome undetermined. However, improvements in 
terms of inclusion of digital processing and automated analysis might expand and 
establish its usefulness in neuro- intensive care particularly if used in conjunction 
with other devices such as the Bispectral Index Monitor (BIS). (78)(79) 
 
3.4.10 Computerised tomography scans 
 
Computerised tomography or CT scans make use of ionising radiation to produce 
detailed (2-dimensional) images of structures inside the body. It is used to 
supplement information obtained by traditional X-rays and ultrasonography 
techniques by giving clearer and more detailed imaging. A CT scan of a patient with 
head injuries can diagnose or exclude tumours, haemorrhage, fractures, or areas of 
infarction. The modern CT machines can produce detailed images within minutes 
unlike a MRI scan (refer to next sub-section 3.4.11) which takes much longer in 
comparison and requires a patient to be able to remain still for a prolonged period of 
time. CT scans are good for visualising bony structures as well as blood vessels and 
bowel. Contrast agents can be given to enhance the images obtained. As with any 
scan that makes use of ionising radiation, caution must be excised when it is used in 
children, pregnant women and those who require repeated CT scans. (80) CT scans 
are generally more widely available and cheaper than MRI scans. 
3.4.11 Magnetic resonance imaging 
 
Magnetic resonance imaging (MRI) is a non-invasive method of providing detailed 
imaging of body cavities. It uses a powerful magnetic field (anything from 1 to 4 
Tesla), to align the hydrogen molecules in body water in the direction of the field. A 
radiofrequency emitter is switched on to produce an electromagnetic field, at 
resonant frequency, to flip the spin of the aligned protons of hydrogen. When the 
field is switched off, the protons decay and give off photons. These photons produce 
the energy that is detected by the scanner. An image is built as these photons in 
different tissues return to their equilibrium states at different rates. By changing the 
parameters on the scanner this effect is used to create contrast between different 
types of body tissue or between other properties. Contrast agents may be injected 
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intravenously to enhance the appearance of blood vessels, tumours or inflammation. 
Contrast agents may also be directly injected into a joint in the case of MRI 
arthrogram imaging of joints. Unlike CT scanning which makes use of ionising 
radiation, MRI scanning is generally very safe and provides better contrast resolution 
compared to CT scanning which provides better spatial resolution. The disadvantage 
of MRI is that scanning takes a considerably longer period of time than a CT scan 
and requires the subject to remain still for a considerable length of time in an 
enclosed space. The strong magnetic field can affect the function of some metal 
implants such as pacemakers or cochlear devices, and the presence of certain metal 
objects in situ in body tissues may be an absolute contraindication to having an MRI 
scan. (78)(79)(80) 
 
None of the above techniques are without their limitations, and none were made for 
the purposes of measuring brain tissue oxygenation per se. The development of a 
new device, able to make use of fibreoptic technology, to obtain signals that could 
measure oxygen saturation in the brain and other body tissues, is an exciting 
prospect, which could potentially transform the next decade of monitoring the 
injured brain.  
 
A device capable of giving accurate, real-time, reliable readings of oxygen saturation 
within the human body does not exist at present. In particular, in relation to an organ 
such as the brain, which is highly sensitive to hypoxia induced damage; a simple 
bedside monitor that could help indicate areas of ischaemia would be invaluable. 
This would contrast with the need for repeated, time consuming and expensive head 
CT or MRI scans. It would not be cost effective or practical to have an MRI scanner 
in every hospital. In most hospitals that house a scanner, there is usually a need to 
transport the patient to a site remote from the ICU; the scan requires critical care 
skilled staff to escort the patient on a potentially hazardous journey in order to 
achieve this. It is difficult to maintain stability of the patients’ condition with 
logistical issues of moving ventilated patients with many lines and monitoring 
connections. So in reality MRI/CT scans are usually reserved for the occasion when 
a patient is deteriorating.  It would also be an inappropriate use of resources to have a 
dedicated MRI scanner for ITUs in District General Hospitals. Most such scanners 
are manned in major trauma centres or neurosurgical centres. 
  45 
3.4.12 Positron emission tomography 
 
Positron emission tomography (PET) scanning is a nuclear imaging technique which 
produces a 3-dimensional colour image of functional processes in the body. Gamma 
rays are emitted by a tracer (positron emitting radionuclide) which is tagged onto a 
naturally occurring substance found in the human body, such as glucose, water or 
ammonia.  A commonly used substance is flurodeoxyglucose (FDG) which can be 
tagged onto glucose. Cancers or abnormal growths that utilise glucose in the body in 
a different way than normal tissue show up as an abnormality on a PET scan. As the 
radiotracer is broken down in the body, the energy emitted produces a 3-dimensional 
image on a monitor. PET scans are usually used in conjunction with MRI or CT 
scans to gain additional information about a diagnosis as well as how effectively a 
treatment is working. (84) 
 
In imaging of the brain, PET scans are useful for diagnosis of movement disorders 
such as Parkinson’s and Huntington’s as well as epilepsy. Images can be obtained by 
using a radiotracer (oxygen molecule) in water which is taken up by the brain and a 
reflection of blood flow; and also by glucose metabolism using deoxyglucose. Blood 
flow and glucose uptake produces images on PET scanning that locate seizure 
activity in the brain. In most patients, blood flow and glucose uptake is increased in 
the cerebral cortex during seizure activity and reduced in the period between 
seizures. In the patient with a head injury, areas of brain damage have reduced blood 
flow and glucose metabolism.(85) 
3.4.13 Summary 
 
In combination with existing methods of monitoring the head injured brain, this 
fibreoptic probe (described in the next chapter) could add to the way we monitor 
patients with head injuries. The probe in question, looks at specific, focal areas of 
oxygenation in the brain, compared to the current global options that are used in 
clinical practice. It is implemented via existing conduits which are in regular use on 
neuro-intensive care units; measurement is not a direct assessment of brain function 
– we make assumptions regarding the likely thresholds of e.g. ICP/Systemic blood 
pressure, when the brain might be at risk of secondary damage. Hence an area of 
need for a monitor capable of real-time direct brain oxygen saturation readings.  
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3.5 Oxygen saturation measurements from brain tissue – on neurosurgical 
patients undergoing elective surgery 
 
After severe head injury, neurosurgery and a number of critical illnesses, the supply 
of blood and oxygen to the brain may be compromised, causing brain damage and 
possibly death. Clinical signs may be too late or unclear, hence the need exists for a 
reliable monitor and early warning system to detect such deteriorations. From the 
introduction, we know that there is no reliable way of determining what really goes 
on inside the human brain. Mechanisms of either head injuries or neurological 
pathologies such as brain tumours manifest in different ways. Given the barriers to 
brain monitoring presented by the vessel rich scalp, the relatively opaque skull and 
the potential severity and life-threatening nature of these conditions, invasive 
monitoring techniques are deemed appropriate and in many specialist centres, are 
routinely used. At The Royal London, one of the leading trauma centres in the 
United Kingdom, ICP monitoring probes are passed onto or into the brain via an 
‘intracranial bolt’, a hollow metal tube (approximately 0.5 cm diameter), which is 
screwed into the skull and has 2–3 channels through which the probes are introduced. 
These allow for monitoring of ICP in patients with unstable head injuries, and trends 
or changes in ICP indicate the need for further investigations or treatment.  
 
After several discussions with the engineers at City University, we approached 
neurosurgeons and intensive care doctors at The Royal London, on their views on a 
probe that could measure oxygen saturation in brain tissue. It was agreed that this 
would have great research value as well as the potential to develop into a novel 
bedside tool for monitoring patients with neurosurgical pathology. In order for the 
idea to work, it had to be of the correct size and dimensions to fit the lumen of the 
cranial bolt that was in routine use on the intensive care unit (ITU) at The Royal 
London Hospital. 
 
With this in mind, this fibreoptic probe was constructed by a member of the 
Biomedical Engineering Research Group, City University, London, with a view to 
evaluating its use in patients. A pilot study was needed to determine whether 
adequate photoplethysmographic (PPG) signals could be obtained from the brain 
tissue and to determine the optimal optical fibre characteristics and depth of 
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penetration of fibres to the brain. If good PPG signals could be obtained, this would 
then allow us to obtain readings in longer durations measurements e.g. for patients on 
the intensive care unit. The protocol for the study was written and ethics and MHRA 
application sort for this in mind. We also needed to liaise with the hospital’s sterile 
services department to ensure that the single-use only probes would be sterile for 
insertion into human tissue.  
 
3.6 Aims 
 
The primary aim of this study was to determine whether adequate PPG signals could 
be obtained from the brain tissue. The study also aimed to verify whether the cranial 
bolt access system could serve as a suitable conduit for the fibres and whether the 
acquired signals would be adequate for calculation of oxygen saturation.  The 
secondary aims were to assess the accuracy of the system, and feasibility for longer-
term measurements. [Later on, measurements of longer duration were also taken 
from a single patient suffering with an acute intra-cerebral haemorrhage in The 
Royal London Hospital ITU; this will be discussed in section 3.10]. 
 
3.7 Protocol and ethics approval 
 
We had full local research ethics committee approval as well as full MHRA approval 
for use of the probe. A pilot study was undertaken intra-operatively in neurosurgical 
patients at The Royal London Hospital, in order to determine whether PPG signals 
could be obtained from the brain tissue, and to determine the optimal optical fibre 
characteristics and depth of penetration of the fibres into the brain (see Appendix A). 
 
 
3.8 Materials and methods 
 
In this study, a dual wavelength optical fibre PPG system was used. The probe 
consisted of two silica optical fibres with a core diameter of 400 µm and a numerical 
aperture (NA) of 0.39. Each fibre is terminated at one end with an SMA connector 
and the other end is cut and polished flat. The fibres are covered in a protective PVC 
jacket, which is stripped away over a length of 16 cm from the distal end. The probe 
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materials are biomedically compatible, and can undergo steam sterilisation at 136 
degree Celsius. The instrumentation is housed in a metal box containing: red (660 
nm) and infrared (850 nm) emitters (LEDs), a PIN photodiode photodetector, a 
battery power supply and a simple signal processing circuit. The signals for each of 
the two wavelengths are recorded and stored on a notebook computer using a 
LabVIEW (Laboratory Virtual Instrument Engineering Workbench) based data 
acquisition system. (Figure 3.1) 
 
LabVIEW is a programme development environment that utilises a graphical 
programming language, G, to create programmes in the block diagram form. It relies 
on graphical symbols, rather than textual language (C, C++, Java) to describe 
programming actions. It is especially suitable for instrument control, data acquisition, 
and pre/post processing of acquired data. LabVIEW programmes are called Virtual 
Instruments (VIs) because their appearance and operation imitate actual instruments. 
The LEDs (light emitting diodes) were both connected to the single optical 
transmitting fibre using a Y- coupler (a bifurcated optical fiber assembly from Ocean 
Optics Inc., Dunedin, FL, USA). The photodetector is coupled directly to a receiving 
optical fibre.  
 
An instrumentation unit is used for the control of the light sources and acquisition of 
signals from the tissue.  This hardware is interfaced to a 16-bit DAQCard-AI-16XE-
50 data acquisition card (National Instruments Inc. Austin, TX, USA) and installed 
into a notebook computer.  The LEDs are driven by a pair of switchable regulated 
current sources, one for each wavelength, supplying 25 mA and 14 mA to the red and 
infrared LEDs, respectively. Timing signals are provided by a programmable counter 
timer built into the data acquisition card. 
 
The photodiode is connected to a differential transimpedance amplifier. The output 
of the transimpedance amplifier is fed into a demultiplexer and the signals separated 
into three components, representing the infrared (IR), red (R) and ambient (AMB) 
light intensities. Any high frequency noise is filtered. The instrumentation is powered 
by two 12 V 1.2 Ah sealed lead-acid batteries. The signals are all fed into the analog-
to-digital converter built into the data acquisition card installed in a notebook 
computer running a LabVIEW software (National Instruments Inc. Austin, TX, 
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USA) Virtual Instrument (VI).  The VI reads the digitized signals at a rate of 100 
samples per second and records the signals in a spreadsheet file.  Figure 3.3 shows a 
photograph of the system. 
 
 
 
Figure 3.3 Photograph of the measurement system, with fibreoptic cables all linked to the 
notebook computer for recording of signals. 
 
This fibreoptic probe had also undergone stringent testing with clinical physics for 
electrical safety and deemed safe and appropriate to be used in this clinical setting. 
The Integra Neurosciences IM-3 Cranial Access System was used in conjunction 
with the fibreoptic probe. This allowed the tips of the optical fibres to be placed 
directly within brain tissue. The IM-3 system is designed to accommodate three 
sensors: an intracranial pressure sensor, a Licox tissue oxygen partial pressure sensor 
and a temperature probe. The Licox and temperature lumens were suitable for the 
insertion of two optical fibres. The IM-3 system comes in a sterile package 
containing a threaded cranial bolt, triple lumen insert and tools to aid insertion of the 
bolt. Essentially, the bolt is fixed into place after burr holes are made, depending on 
the location of the pathology, by the neurosurgeons, under sterile surgical conditions. 
The bolt is screwed into the burr hole until the thread is almost concealed by the 
skull. The triple-lumen insert is passed through the lumen of the bolt so the distal end 
penetrates the brain tissue. A compression cap, attached to the body of the insert, is 
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tightened onto a thread on the rear of the cranial bolt, compressing a hollow 
cylindrical silicone washer in the assembly. This washer expands, achieving a tight 
seal between the assembly and the bolt. Figure 3.4 below shows a close up picture of 
the IM-3 cranial access kit. 
 
 
Figure 3.4 IM-3 cranial access kit with the cranial bolt, drill bit, insert, dural perforator and 
self-sealing leur caps. A fifty pence piece is shown for scale. 
 
There are luer hubs at the proximal end of the triple-lumen assembly with special 
inter-locking luer caps.  Each cap has a patent channel through which the 
corresponding probe can be threaded.  Tightening the cap causes longitudinal 
compression of a silicone washer, which expands inwards producing a seal around 
the probe.  A cross sectional diagram of the bolt in situ is shown in Figure 3.5. A 
photograph of the bolt with fibres is shown in Figure 3.6. The intracranial bolt is 
designed to be left in place for several days enabling ICP and other measurements to 
be made for the length of time that is needed in a critically ill patient.  
 
Written, informed consent was obtained from patients undergoing elective 
neurosurgery, at The Royal London Hospital, Whitechapel. They patients were all 
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given a general anaesthetic and their airway secured. They were all intubated and 
their lungs mechanically ventilated for the operation. A triple-channel IM-3 integra 
cranial bolt was inserted by the neurosurgeon undertaking the operation. The 
neurosurgical patients only received a bolt temporarily as they invariably required a 
craniotomy (removal of a small part of the cranium). The most common operations 
were the removal of tumours or clipping of aneurysms.  In order to perform a 
craniotomy, one or more burr-holes are initially drilled, and one of these holes was 
used for the temporary placement of the bolt. The fibres were then inserted via the 
bolt, until at a depth of 5 mm into the brain, and PPG signals were recorded for 
several minutes. 5 mm was chosen as a suitable depth of penetration to ensure that 
the detected light was entirely from brain tissue and not from any other tissue 
encompassing the brain. This would also ensure that the fibres protruded fully from 
the end of the cranial bolt assembly. As a routine part of the anaesthetic, each 
patient’s arterial oxygen saturation was also monitored using a commercial finger 
pulse oximeter. After the monitoring period, the fibres and the bolt were removed 
and the surgery resumed.  
 
 
 
 
 
Figure 3.5 Cross-sectional diagram of bolt in situ when taking readings from the brain. 
Adapted from (86). 
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Figure 3.6 Photograph of the fibres and cranial bolt. 
 
3.9 Results 
 
In total, six patients (four males, two females) aged between 46 and 70 requiring 
elective neurosurgery were studied. An estimation of oxygen saturation was made by 
retrospectively analysing the red and infrared samples. A visual inspection was done, 
selecting the best waveform in terms of height and amplitude and minimal artefacts. 
The arterial oxygen saturations were estimated from the cardiac-modulated 
components of the signal using a LabVIEW virtual instrument incorporating a fast 
Fourier transform algorithm for analysis.  
 
The amplitude of the pulse peaks in each amplitude spectrum were then calculated 
and normalised by dividing by the amplitude at zero frequency (i.e. DC components) 
in each spectrum. The cerebral arterial oxygen saturation, ScaO2 was estimated using 
an empirically derived formula for estimating oxygen saturation in pulse oximetry 
from the ‘ratio-of-ratios’ (enclosed within the parentheses in the Equation 3.1):  
 
€ 
ScaO2 =110 − 25
Acard ,R ADC ,R
Acard ,IR ADC ,IR
# 
$ 
% 
& 
' 
(             (3.1) 
where Acard,R and Acard,IR are the red and infrared cardiac peak amplitudes and ADC,IR 
and ADC,R  are the amplitudes of the infrared and red spectra at zero frequency. (33) 
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The long duration data was broken down into blocks of 60 seconds. A continual 
estimation of the arterial and venous oxygen saturations was produced from 
successive data blocks utilising the same software algorithm used for the short 
duration measurements.  Though signals were successfully obtained from all the six 
patients studied, they did differ in quality between the patients. Due to this, and the 
relatively small sample population, the results from each patient will be described 
and considered separately. To compare each waveform between the patients, each 
waveform was divided by the total intensity i.e. AC signal divided by DC signal and 
the waveforms inverted. Signals were successfully obtained at both wavelengths for 
all patients.  A sample trace obtained from each patient are shown and discussed 
below.  
 
Patient One: 
 
The first patient was a 24 year old male who needed a craniotomy for the clipping of 
a cerebral aneurysm. At the time of insertion of the probe, his heart rate was 62 beats 
per minute with a blood pressure of 122/67 mmHg and mean arterial pressure of 85 
mm Hg. His peripheral SpO2 reading was 99% throughout.  Good PPG signals were 
obtained, with minimal artefact for more than 60% of the recording time period (total 
recording time of 260 seconds). A typical 30 second tracing obtained from this 
patient is shown in Figure 3.7. 
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     (a) 
 
     (b) 
Figure 3.7 Infrared (a) and red (b) normalised PPG signals recorded from patient number 
one. Adapted from (8). 
 
Patient Two: 
 
This second patient was a 38 year old male who required a craniotomy for the 
resection of a tumour. His heart was 70 beats per minute, with a blood pressure of 
130/82 mmHg, mean arterial pressure of 98 mmHg at the time of recording. The 
peripheral SpO2 reading was 99% throughout the measurement period. Total 
recording time was 276 seconds. A 30 second trace obtained from this patient is 
shown in Figure 3.8. There was interference with the signals for about half the period 
that signals were recorded. One very likely major contributing factor as the source of 
the interference was the Stealth Surgical Navigation System (Stealth Inc., Earlysville, 
VA, USA). This Stealth system is frequently used in this sort of surgery to locate and 
identify tumour positions accurately in the brain.  Each patient has a CT or MRI scan 
beforehand which is fed into the Stealth imaging system. The imaging system 
enables the position, in 3-dimensions, of tumours to be pinpointed by a ‘wand’ held 
by the operating surgeon. The ‘wand’ is positioned in relation to fixed markers on the 
patient’s scalp and the corresponding images are displayed from its database of CT 
or MRI scans. Thus tumours and other structures in the brain can be readily and 
accurately identified and located by the surgeon, to aid in the excision of the tumour. 
This Stealth system makes use of a pulsed infrared light source with a rate of 20 Hz. 
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As the pulsed periods from this Stealth system are brief in nature, interference is only 
detected at those intervals at which measurement of the PPG signals coincides 
directly with the pulsed frequency from the Stealth. The fibreoptic probe 
measurements occur at a frequency of 100 Hz. To counteract this problem, the use of 
a low pass filter system would abolish any traces of interference. 
 
 
      (a) 
 
      (b) 
Figure 3.8 Infrared red (a) and red (b) normalised PPG signals recorded from patient number 
two. Adapted from (8). 
 
 
Patient Three: 
 
Patient number three was a 31 year old female patient who underwent a craniotomy 
for the resection of a brain tumour. This patient had a heart rate of 54 beats per 
minute and blood pressure of 106/58 mmHg with a mean arterial pressure of 74 
mmHg at the time of the recording. The peripheral SpO2 readings were 98% 
throughout. Clear signals, without interference was obtained for more than 80% of 
the recording. Total recording period was 286 seconds. The frequency of the 
interference in this patient was of low frequency and corresponded to the rate of 
mechanical ventilation. Thus, this interference was very likely due to ventilator 
induced changes in the cerebral circulation. A typical 30 second trace obtained from 
this patient is shown in Figure 3.9. 
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      (a) 
 
      (b) 
Figure 3.9 Infrared (a) and red (b) normalised PPG signals recorded from patient number 
three. Adapted from (8).  
 
 
Patient Four: 
 
Patient number four was a 76 year old male patient who had a craniotomy for the 
resection of a brain tumour. At the time of the recording, he had a heart rate of 58 
beats per minute, blood pressure of 118/57 mmHg, mean arterial pressure of 84 
mmHg. His peripheral SpO2 readings were 99% throughout. Signals were obtained 
for a brief period (total recording time of 148 seconds) with interference in about half 
that time span. A 30 second trace obtained from this patient is shown in Figure 3.10. 
The PPG signals obtained were of poor quality in general. The reason why is 
uncertain. It could be that the fibres were not in far enough or that the duration of the 
monitoring period was not long enough. Part of the problem could be that the fibres 
placed by the operating surgeon was not in a region of the brain with adequate blood 
flow, hampered by the time factor in that the operating surgeon needed to proceed 
with the operation urgently, and hence the period of recording was shorter than 
anticipated. 
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      (a) 
 
      (b) 
Figure 3.10 Infrared (a) and red (b) normalised PPG signals recorded from patient number 
four. Adapted from (8). 
 
Patient Five: 
Patient number five was a 60 year old patient who had a craniotomy for resection of 
his brain tumour. He had a heart rate of 66 beats per minute, blood pressure of 
116/55 mmHg, mean arterial pressure of 75 mmHg at the time of recording. His 
peripheral SpO2 readings were 99% throughout. The signals were recorded for a total 
period of 525 seconds with good signals i.e.no interference for >85% of the time. 
There were some excellent PGG waveforms obtained with good demarcations. There 
was some minor interference, which corresponded to the respiratory frequency of the 
patient. The signals obtained here were atypical from what was expected in this 
patient in that the amplitude of the red PPG waveform was larger than that of the 
infrared one. A 30 second trace is shown in Figure 3.11. This is usually seen when 
the arterial oxygen saturation falls below 85% when using a standard pulse oximeter. 
The subsequent calculated oxygen saturation was thus spuriously low as shown in 
Table 3.5.  
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      (a) 
 
      (b) 
Figure 3.11 Infrared (a) and red (b) normalised PPG signals obtained from patient number 
five. Adapted from (8). 
 
Patient Six: 
 
Patient number six was a 44 year old female patient who had a craniotomy for the 
clipping of a cerebral aneurysm. At the time signals were taken, she had a heart rate 
of 50 beats per minute, a blood pressure of 126/60 mmHg, mean arterial pressure of 
82 mmHg. Her peripheral SpO2 readings were 100% throughout the measurement 
period. Total recording time was 257 seconds. Both the red and infrared signals were 
of good quality and had good demarcation, with no interference for greater than 70% 
of the recording. A 30 second trace obtained from this patient is shown in Figure 
3.12. 
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      (a) 
 
      (b) 
Figure 3.12 Infrared (a) and red (b) normalised PPG signals from patient number six. 
Adapted from (8). 
 
The acquired red and infrared signals from all six patients were used to estimate the 
cerebral oxygen saturation of each patient. They were analysed retrospectively using 
60-second samples of each waveform. This sample was chosen by visual inspection 
using the ‘best’ signal in terms of overall quality of the waveform. Waveforms with 
large amplitudes and minimal artefacts were selected. The arterial oxygen saturation 
was estimated from the cardiac-modulated components using a Fourier transforms 
algorithm for analysis. To summarise, the estimated values of oxygen saturation for 
each of the six patients are shown in Table 3.5.  
 
Patient number Estimated oxygen saturation (%) 
1 98.2 
2 100.5 
3 94.8 
4 90.4 
5 52.0 
6 92.6 
Table 3.5 The estimated values of oxygen saturation in each of the six patients. 
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3.9.1 Discussion 
 
This was a successful pilot study on the use of a specially built fibreoptic probe 
designed to measure PPG signals from brain tissue. These initial results are 
promising in that adequate signals were obtained from brain tissue. In addition, it 
confirmed the feasibility of using existing cranial bolts to house the fibres with no 
untoward effects. 
 
In one of the patients (number three), this patient appeared to be more prone to 
ventilator artefacts in the signals obtained. This could be because the patient might 
have been relatively hypovolaemic, resulting in an exaggerated effect in blood 
pressure with mechanical ventilation. It could also have been due to individual 
sensitivity to mechanical motion from the ventilator. 
 
It has to be noted, that relatively deoxygenated blood, absorbs red light more strongly 
than infrared light and any vessels with a transmitted pulse, including cerebral veins 
will give a large amplitude PPG signal. The implication that the blood is of low 
oxygen saturation may not always be due to arterial saturation readings but venous 
ones. The brain is enclosed in a fixed cavity and any fluid such as cerebrospinal fluid 
may contribute to pulsation in nearby large veins. Thus, the relatively low oxygen 
saturation reading in one of the patients (number five) could be due to the probe 
being in close contact with a large vein. Since it was not possible for us be sure 
where the cerebral vessels are in location to the burr hole once it is made, the 
placement of the bolt cannot be altered and readings could only be taken from that 
site. Thus the PPG signal could be influenced by any pulsatile vessel, and it would be 
difficult at this stage to distinguish between a vein or artery. This could have also 
been due to just differences in anatomical variation. This will need to be studied 
further, before any further comments can be made. The poor quality signals obtained 
from patient number four was attributed to the possibility that the fibres were not in 
the correct position i.e. one fibre was in further than the other, leading to a poor 
signal. There were no complications associated with insertion of the probe in all the 
patients studied. There was no bleeding, no attributable deleterious neurological 
sequelae such as seizures, or neurological deficits or any associated signs of 
infection. 
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3.9.2 Conclusions 
 
This proof of concept study showed that that satisfactory quality red and near-
infrared PPG signals could be obtained directly from human brain tissue with a 
fibreoptic probe, using the cranial bolt as a conduit for the fibres. The results of this 
study are certainly encouraging, and it would be interesting to see whether this 
method could yield similarly good results over a prolonged period of monitoring in 
the long term.  Indeed further research and comparisons to other techniques currently 
available such as near-infrared spectroscopy may be warranted.  
 
3.10 Measurement of brain oxygen saturation on the intensive care unit 
 
In patients suffering from head injuries, secondary brain damage caused by neuronal 
lack of oxygen and blood supply is a common and potentially preventable cause of 
mortality and residual disability. By monitoring the pulse waveform and cerebral 
oxygen saturation, it may be possible to alert the clinician to changes in the clinical 
condition of the patient allowing appropriate therapy to be given with a view to 
improving patient outcome. Near infrared spectroscopy (NIRS) is currently used to 
monitor adequacy of cerebral perfusion by estimating oxygen saturation. Although 
this has the advantage of being a non-invasive technique, it has been suggested that 
the accuracy of NIRS is compromised by attenuation and modulation of light by 
superficial tissues e.g. skull, scalp. (8) Electrochemical oxygen sensors are also used 
transcranially in severe head injury cases. These systems have the disadvantage of 
requiring calibration prior to insertion, need to stabilise and respond (can take up to 
two hours to achieve stability), and are prone to inaccuracies caused by small 
haemorrhages around the sensor. 
 
From the results obtained in the previous six patients, we concluded that we could 
obtain good quality PPG signals from brain tissue. We thus used the knowledge 
gained to obtain signals from brain tissue of a patient on the ITU at The Royal 
London who was in need of an intracranial bolt and ICP monitoring whilst 
recovering postoperatively on the unit.  
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We proceeded with a separate clinical study in a different clinical setting, which had 
full ethics committee approval. The primary aim of this study was to see whether we 
could obtain clinically meaningful signals for a prolonged period and to compare this 
with oxygen saturation values obtained from haemoximetry as well as the Near-
Infrared Spectroscopy (NIRS). A secondary aim of this study was to see if any 
changes in ICP measurements correlated in anyway to PPG signals obtained. 
 
3.10.1 Materials and methods 
 
The triple channel IM-3 cranial access bolt used in the first clinical study on elective 
neurosurgical patients is also readily available for use in ITU patients, specifically 
those on the ITU at The Royal London Hospital. Currently, the bolt is designed to 
accommodate three sensors, one for ICP monitoring, one for Licox oxygen tissue 
sensor measurements and the last for temperature monitoring. In practice, at the ITU 
in The Royal London Hospital, only the ICP monitoring channel is used, thus, there 
were two other free channels for the insertion of the optical fibres for purposes of this 
study. The cranial bolt is designed to remain in place for several days, allowing the 
continuous monitoring of ICP in critically ill head injury patients. The IM-3 cranial 
bolt comes in a sterile packaging and is inserted usually in the operating theatre 
under fully sterile conditions. It is inserted under direct vision, by the neurosurgeons, 
after the formation of a burr hole in the scalp, and screwed in so that it sits tightly 
and securely. The fibres can then be passed through the lumens to rest directly on 
brain tissue. After analysis from the previous study, it was decided that the fibres 
would rest no more than 4 mm onto the brain tissue, to provide the best conditions 
for obtaining long-term readings using a minimally invasive technique. 
 
In this study, a modification was made to the measurement system, in order to 
improve accuracy. A third light source close to the isobestic wavelength of 805 nm 
was added. This wavelength is the isobestic point for oxy and deoxy-haemoglobin, 
i.e. the wavelength at which the two haemoglobins have the same absorption of light. 
Any changes in the oxygen saturation of the blood would have minimal effect on any 
backscattering of light. As the only readily available LED was one with a wavelength 
of 810 nm, this was used instead.  
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In order to incorporate three light sources from one fibre to obtain measurements 
from three wavelengths of light, the three light sources had to be channelled into one 
single fibre. In the previous study, for the two lights sources, a commercially 
available Y-coupler was used (i.e. a bifurcated optical fibre). There was no 
commercially available coupler for three light sources, so this was custom made by 
our biomedical engineering group. A trifurcated fibre was made consisting of three 
short optical fibres of 400 µm in core diameter, joined to single larger fibre of 
800 µm in core diameter which terminated at the distal end with an SMA connector. 
All fibres were threaded into a metal tube, optical adhesive applied to the un-
terminated ends of the fibres and the entire construction supported by the application 
of strong PVC tape. The original infrared wavelength of 850 nm was also substituted 
for a light source with a wavelength of 940 nm as it was felt that 850 nm was too 
close to the wavelength of 810 nm to add any further value to the measurements. 
 
3.10.2 Patient recruitment 
 
The patient recruited was a 78 year-old female who was on the ITU at The Royal 
London Hospital for intensive care support following evacuation of an intracerebral 
haematoma in the frontal-temporal region. This patient initially presented to hospital 
with a GCS score of 3. She was a known hypertensive with a resting blood pressure 
of 165/64 mmHg. The patient had an urgent CT scan of her brain that showed the 
extent of the intracerebral haematoma and the need for urgent surgical intervention. 
The patient was taken to theatre to have a craniotomy to evacuate a haematoma and 
subsequently was kept temporarily sedated on a ventilator whilst recovering. As part 
of routine monitoring, an ICP bolt was inserted into the skull of the patient in 
theatres, so that ICP pressures could be monitored in the patient whilst on the ITU.  
Assent was obtained from the patient’s next of kin. The fibreoptic probe was inserted 
into the spare ports on the cranial access bolt in order to record PPG signals. This 
occurred after about 20 hours from the initial time of presentation of the patient to 
hospital. The probe was placed approximately 4 mm into the region of the right 
frontal lobe and signals were recorded for a total period of six hours.  
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As part of routine ITU monitoring, the patient had continuous monitoring with a 
commercial peripheral (finger) pulse oximeter as well as an indwelling arterial line- 
allowing regular measurements of blood gases including blood oxygen saturation 
using a haemoximeter. The patient was sedated with propofol, an intravenous 
anaesthetic, intubated and lungs mechanically ventilated throughout the six-hour 
monitoring period with the fibreoptic probe. In addition a pair of NIRS sensors 
(Somanetics Corporation, Troy, MI, USA) was placed on the patient’s forehead as 
per manufacturer’s instructions and readings were taken at intervals from the NIRS 
monitor. The readings were taken over a six-hour period. During this time, the 
arterial oxygen saturation (SpO2) from the commercial pulse oximeter was recorded 
manually and the arterial oxygen saturation (SaO2) was measured from samples 
taken from the arterial line using a haemoximeter. In total, 54 pulse oximetry 
measurements and five haemoximeter measurements were recorded during the six-
hour period.   After about six hours, the patient started to move and wake up so the 
probe was removed and the monitoring discontinued. The patient was on the ITU for 
several days, and made a satisfactory recovery. 
 
3.11 Results 
 
In the first pilot study, the measurements were made over short time periods in the 
region of minutes. The average value for oxygen saturation was calculated for each 
patient using a single Fourier transform of fixed length.  In this study, the signals 
were recorded over a period of hours, and the calculations made some time after the 
signals were acquired. The data was analysed by breaking the data down into a series 
of sets of one-minute in duration and a pair of discrete Fourier transforms applied to 
each set; one for each of the infrared and red channels respectively. Each pair of 
Fourier transforms was used to generate estimations of oxygen saturations from the 
peaks occurring at the cardiac (SfcO2) and respiratory (SfrO2) frequencies.  Estimates 
were also made of the heart and respiratory rates from each data set. The data was 
analysed using specifically tailored LabVIEW VI programme. This analyses the data 
after the upper and lower limits of the cardiac or respiratory frequencies are manually 
entered. When the programme is run, red and infrared signals are recorded from the 
spreadsheet file. The main body of LabVIEW VI is contained within a loop, each 
time a loop runs, one-minute data sets are selected from the data in sequence. As the 
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sets are contiguous, 60 sets of data are obtained for each hour of recording, and fed 
into the ‘amplitude spectrum’ functions which produce two discrete Fourier 
transforms, in the form of one-dimensional numeric arrays. A sub-set of each 
spectrum (sub-spectral array) is produced which consists the part of each spectrum 
with either the cardiac or respiratory peaks. An array of red and infrared peak sizes is 
generated and saved to a spreadsheet file. The continuous oxygen saturations for 
‘cardiac’ and ‘respiratory’ cerebral oxygen saturations, SfcO2 and SfrO2, were 
estimated from the acquired DC signals. The values of SfcO2 were compared to a 
commercial finger pulse oximeter. A paired Student’s t-test was used to see if there 
was any significant difference between the two. (88)(87)  
 
In order to calculate the arterial oxygen saturation, the ratio of ratios (89) is averaged 
over a finite period consisting of n cardiac cycles. The mean value of (88) is used to 
estimate the arterial oxygen saturation (SpO2) according to the Equation (3.2) 
below(4): 
 
ScO2 =110 − 25RR     (3.2)            
 
The signals from the ITU patient were successfully recorded over the monitoring 
period.  The total time period of monitoring was 353 minutes.  
 
 
Figure 3.13 shows a 20-second sample of the normalised PPG signals obtained from 
the patient. It can be seen that both the red (660 nm) and infrared (940 nm) signals 
are fairly consistent in amplitude and consistency. There is some degree of 
modulation of the waveform consistent with frequencies in the respiratory range, but 
not to the extent seen in the first study on the intra-operative neurosurgical patients.  
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Figure 3.13 Sample of PPG signals obtained from patient number six. The first trace shows 
the infrared signals; the second trace the red signals. Adapted from (33). 
 
During the six-hour measurement period, the SfcO2 was significantly lower than the 
finger SpO2 (P<0.001) and the blood SaO2 (P<0.001) as confirmed by paired 
Student’s t-tests.  A steady trend of decreasing SfcO2 was seen for the first four hours 
followed by a gradual rise. The mean (±SD) difference between SfcO2 and finger 
SpO2 (in saturation units) was -7.47(±3.4)% n=54. The mean (±SD) difference 
between SfcO2 and blood SaO2 was -7.37(±2.8)% n=5.   
 
In terms of difference between that obtained from the calculated mean cardiac versus 
respiratory frequencies SfcO2 and SfrO2, in saturation units, was 15.4 ±(6.04)%. A 
paired Student’s t-test on all the one-minute sets of data showed that the values of 
SfrO2 were significantly lower than those of SfcO2 (P<0.001). 
 
Heart rate from the commercial ECG monitor (GE Healthcare Clinical Systems, WI, 
USA) was also compared to the trace obtained by the fibreoptic probe. The mean 
(±SD) difference between the heart rate obtained by the fibreoptic probe and the 
commercial ECG monitor was -2.31(±11.6) min-1, n=46. There was thus good 
correlation during most of the monitoring period between the two.  
Overall, there were just two periods in the whole period of monitoring when the 
photodetector output was abnormally low, and in both cases were associated with 
movement of the patient’s head, and the fibres just needed to be re-positioned in 
order to rectify this.  
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3.11.1 Comparison with ICP 
 
Throughout the monitoring period, ICP values were within normal limits i.e. less 
than 20mm Hg. Whilst there was a gradual decrease in the first four hours of the 
monitoring period, as the sedation was lightened, the patient began to wake up and 
move, with an increase in mean arterial pressure (MAP) as well as ICP towards the 
end of the monitoring period. The readings in SfcO2 were observed to be similar to 
the pattern seen with the changes in ICP. The other variable which could affect ICP 
readings was the end tidal CO2 (Et CO2) which remained within normal limits, but 
did decrease slightly during the period of monitoring. 
 
One of the reasons for adding the third wavelength of light (810 nm) was to allow for 
the calculation, using the Beer Lambert’s Law, of changes in cerebral blood volume 
(CBV). Cerebral blood volume is a major factor in the regulation of cerebral 
haemodynamics. Any increase in cerebral blood volume is associated with the 
dilatation of pial vessels (the vessels that transport substances from cerebrospinal 
fluid to blood) and a rise in intracranial pressure. This in turn causes a decrease in 
cerebral perfusion pressure. This may in itself lead to a reduction of vasodilatory 
capacity or in practice a reduction of cerebral blood flow (CBF). Combined 
measurements of CBF and CBV allows for the calculation of the CBF/CBV ratio. 
This ratio can give an indication of local cerebral perfusion pressure (CPP). CBF and 
hence CPP is autoregulated in the normal brain and is governed by the Equation 
(3.3): 
  
CPP= MAP- ICP (and sagittal sinus pressure)    (3.3) 
 
Where MAP = Mean arterial pressure: 1/3(systolic pressure - diastolic pressure) + 
diastolic pressure. In the normal brain, intracranial pressure and sagittal sinus 
pressure are negligible compared to systemic arterial pressure, and CPP is roughly 
equivalent to MAP. Cerebral blood flow is governed by the Equation (3.4) below: 
 
    CBF= CPP/CVR         (3.4) 
 
where CBF is the cerebral blood flow and CVR is the cerebral vascular resistance 
  68 
Thus, autoregulation is governed by changes in CVR. According to the Hagen-
Poiseuille equation, which governs the flow of Newtonian fluids in tubes, an 
estimation of the factors that govern cerebral vascular resistance can be made. This 
suggests that the resistance is inversely proportional to blood viscosity and the fourth 
power of the radius of the vessel. Any decrease in cerebral perfusion pressure 
automatically causes a dilatation of precapillary resistance vessels, and any increase 
produces constriction. The average hemispheric cerebral blood flow is maintained at 
a fairly constant level, near 50 ml/100 g per minute in the adult human brain at rest 
by adjustments in the diameter of these cerebral resistance vessels. 
 
There are three main theories behind the way autoregulation is controlled, namely: 
the myogenic, neurogenic and metabolic mechanisms of autoregulation. 
 
a) myogenic theory: reflex changes in the tone of arteriolar smooth muscle are 
elicited by changes in transmural pressure. This is based on work done by Bayliss 
(1902). According to this theory, an increase in the transluminal pressure leads to 
stretching of smooth muscle within the vessel wall. Reflex contraction of radial 
fibres then results in constriction of vessel diameter. An opposite effect is seen with a 
decrease in transluminal pressure. (84)(90) 
 
b) neurogenic theory: nerve fibres are known to exist around the cerebral vessels. 
The pial vasculature is richly supplied by noradrenergic sympathetic nerve fibres 
which originate mainly from the superior cervical ganglion. These fibres accompany 
the arteries and arterioles as they penetrate into and are distributed by the brain 
parenchyma. There is also increasing evidence for a serotonergic innervation 
originating from the raphe nucleus. It is also thought the substances such as EDRF 
(endothelium derived relaxing factor) is a factor in relaxation of the cerebral 
vasculature.  
c) metabolic theory: a change in cerebral blood flow initiated by a change in 
perfusion pressure leads to a change in the local concentration of vasoactive 
substances normally eliminated by the bloodstream. This shift in concentration 
would affect the vascular smooth muscle in the direction of an auto-regulatory 
response. Factors such as CO2, pH and O2 were likely contributors to the metabolic 
regulatory response. 
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Thus several theories exist as to exactly how cerebral blood flow is autoregulated. 
However, pathological conditions such as an intracerebral tumour, aneurysm or any 
insult to the brain secondary to trauma, can and does disrupt the regulation of 
cerebral blood flow and brain metabolism.  
 
3.12 Discussion 
These results demonstrated that good quality three-wavelength signals could be 
successfully obtained from the brain tissue over a prolonged period of time. The 
monitoring period was only terminated as the patient was waking up. There were no 
technical failures or major problems with the system as a whole. The probe also 
fitted nicely down the port of the existing triple lumen system.  
 
A possible reason why the oxygen saturation SfcO2 was significantly lower than 
SpO2 measured by the commercial pulse oximeter could be attributed to venous 
pulsation as opposed to arterial pulsation being detected by the probe. There was also 
similarity observed between SfcO2 and ICP readings in terms of a positive 
correlation. During an increase in ICP, venous pulsation may be impeded resulting in 
a truer reading from the SfcO2 compared to actual arterial values. Another factor 
which might have affected readings was the overall volume status of the patient. 
Central venous pressure readings were not noted. However, as blood loss was 
minimal for the surgery and blood gas results indicated good gas exchange, and that 
the patient was on intravenous fluid therapy for the duration of the operation, it could 
be assumed that she was adequately filled. The estimated changes in cerebral blood 
volume was negligible for the first half of the monitoring period, as one might expect 
for a patient that was sedated and ventilated, and then rose as the patient started to 
wake up. 
 
The NIRS monitor was attached to this patient for part of the period of monitoring. 
NIRS monitors give a global indication of oxygen saturation of a specific volume of 
blood: mixed venous, arterial and capillary blood. However as the NIRS monitor 
measures global oxygen saturation (i.e. may not necessarily reflect any changes in 
overall oxygen saturation), it needed to be compared to estimated mixed venous 
saturation (SmO2) in the brain in order to make any true comparisons. In order to 
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make any estimation of global oxygen saturation of the brain, calculation of cerebral 
blood volume would be needed along with computer modelling and simulation in 
order to provide a rough estimate. As there is no “gold standard” to compare cerebral 
arterial as well as venous saturations against, this leaves it difficult to make any true 
interpretations on the limited NIRS readings taken from the one patient. 
 
3.13 Conclusions 
The primary aim was to see whether viable PPG signals could be obtained from the 
human brain. The initial pilot study showed this to be possible. This allowed us to 
continue with using the probe to acquire PPG signals over a longer period on the ITU 
in patients who required an ICP bolt for their head pathology. 
 
There was, however, only one patient studied on the ITU, making it difficult to 
comment further on its use in this setting. However, the results obtained were 
promising with no untoward side effects in the patient studied. The reason behind the 
lack of recruitment of more patients was because the hospital’s own sterilisation 
service was closed during the intended period of study recruitment, and as a result of 
the regulations and restrictions imposed by the substituted outsourced company, we 
were unable to arrange for sterilisation of the fibres. Essentially, their management 
was unwilling to accommodate sterilisation of the fibres for purposes of the research 
study, despite reassurances and documented, evidence-based confirmation of both 
their suitability and regular use for biomedical use. Despite this, the feasibility of 
using this probe as a way of monitoring the brain over a prolonged period of time 
remains a possibility and justifies performing more research using this probe. 
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CHAPTER FOUR–MEASUREMENT OF OXYGEN SATURATION VIA THE 
OESOPHAGUS 
 
4.1 Introduction 
 
In chapter three it was stated that pulse oximetry is part of routine monitoring in 
anaesthesia and intensive care medicine. In fact, in the 1980s, it became a mandatory 
standard for monitoring during anaesthesia. It is also widely available in many other 
clinical settings, and used as part of routine care on many hospital wards and clinical 
areas. Although pulse oximeters generally produce reliable signals and is widely 
available in most clinical settings, there are significant limitations on the accuracy 
and availability of pulse oximeter data in some circumstances. Ironically, the use of 
conventional pulse oximetry in those groups of patients where continuous monitoring 
of oxygenation status would be most beneficial, their physiological condition can 
lead to errors or discrepancies in measurements.   
 
When peripheral perfusion is poor, as in states of hypovolaemia, hypothermia, 
vasoconstriction, low cardiac output states and states of low mean arterial pressure; 
oxygenation readings become extremely unreliable or cease altogether. There are 
also certain groups of patients, such as those who have suffered extensive burns 
and/or damage to skin and extremities, in whom the use of pulse oximetry can be 
extremely limited and inaccurate. As such, the need for a good pulse waveform trace 
is almost unobtainable in such cases. Under these conditions, some pulse oximeters 
give a blank screen on the display or give a message such as ‘low quality signal’ or 
‘inadequate’ signal or simply a poor trace. Thus, the presence of a functioning pulse 
oximeter should not be construed as evidence of adequate tissue oxygenation or 
oxygen delivery to vital organs. 
 
To overcome the inherent limitations of current commercial pulse oximeters where 
peripheral perfusion is compromised, Kyriacou et al of the Biomedical Engineering 
Research Group at City University, developed an innovative oesophageal probe, that 
allowed pulse oximetry measurements to be evaluated in anaesthetised patients. (89) 
(90) In the evaluation of their probe, they successfully demonstrated that measurable 
PPG signals and SpO2 values could be detected in the oesophagus of healthy patients 
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during anaesthesia and from patients undergoing cardiothoracic surgery. A further 
development was the design of a fibreoptic probe that could measure clinically 
meaningful PPG signals from various sites, including the oesophagus and other 
cavities such as the intra-abdominal cavity. 
 
The limitations of current commercial pulse oximetry technology were previously 
discussed. The need for commercial pulse oximeters to be attached to the peripheral 
parts of the body is the reason for one of its major limitations: the need for an 
accessible peripheral pulse/perfusion so that it can be used accurately to obtain any 
readings. The problem with this is pulsatile flow can be easily impeded in certain 
situations and considerably negates its use in certain population groups for example 
patients with severe burns or those whose perfusion is poor due to vascular disease or  
who are hypothermic. In addition, the need to use certain classes of drugs, in high 
risk patients undergoing major surgery, such as adrenaline or noradrenaline, can 
cause significant vasoconstriction in the periphery and hence inaccuracies when 
pulse oximetry is in use.  It can be argued that this is probably the group of patients 
who need to have their oxygen saturation monitored most closely and yet are unable 
to, due to the limitations of the commercially available pulse oximeter. 
 
One possible way of overcoming the problem of being able to accurately measure 
oxygen saturation in states of poor peripheral perfusion, is to try and obtain those 
measurements from internal sites in the human body, one such site being the 
oesophagus. The oesophagus itself is a fairly straight muscular tube (roughly 23 to 
25 cm long) that extends from the pharynx to the stomach and signifies the start of 
the human alimentary tract. It follows the curve of the vertebral column as it 
descends through the neck and posterior mediastinum. The oesophagus begins in the 
midline at the level of the lower cricoid border (C6). It then moves to the left side of 
the neck before returning to the midline at T5. It then extends to the gastric cardia at 
T7. At the level of T10, it passes through the oesophageal hiatus at the level of the 
diaphragm. It ends at the level of T11 at the gastric cardiac orifice. In the upper 1/3, 
the wall is formed from striated muscle, the middle 1/3 is formed of mixed smooth 
and striated muscle whilst the lower 1/3 is formed of smooth muscle. At the inferior 
end lies the oesophagogastric junction where the oesophageal sphincter acts as a 
physiological means of preventing gastric reflux. 
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Anatomically it is divided into three parts: cervical, thoracic and abdominal which 
follows its blood supply. The cervical part is supplied by branches of the inferior 
thyroid artery, the thoracic part by branches of the descending aorta and bronchial 
arteries and the abdominal part by branches of the left gastric and inferior phrenic 
artery. The venous drainage is similarly divided.  The cervical part is drained by the 
inferior thyroid veins, the thoracic by the azygos, hemiazygos and accessory azygos 
veins and the abdominal part by the abdominal azygos and left gastric vein. Since the 
left gastric vein is a tributary of the portal vein (forming a portal-systemic 
anastomosis), in portal obstruction, these veins may varicose and burst into the lower 
oesophagus causing a fatal bleed. (91) 
The cervical part of the oesophagus is supplied by rami from the recurrent laryngeal 
nerves and cervical sympathetic trunks; the thoracic part is supplied by branches of 
the vagus, oesophageal and sympathetic trunks and greater splanchnic nerves. The 
abdominal part is supplied by the vagal and thoracic sympathetic trunks, the greater 
and lesser splanchnic nerves and the plexuses of the left gastric and inferior phrenic 
arteries. The lymph drainage is to the deep cervical, posterior mediastinal and left 
gastric nodes which lead onto the coeliac nodes and eventually the thoracic duct. 
Kyriacou et al. described a reflectance oesophageal pulse oximetry system which 
consisted of a oesophageal probe comprised of two infrared and two red LEDs (of 
peak emission 880 nm and 655 nm respectively) arranged adjacent to a photodetector 
and was designed to fit into a size 20 French gauge plastic transparent disposable 
naso-gastric tube. (92) In a clinical trial of the system by Kyriacou et al, the 
oesophageal probe was used and compared with the peripheral pulse oximeter (SpO2) 
in 49 patients undergoing hypothermic cardiothoracic bypass surgery. 
Photoplethysmographic signals were observed at various depths in the oesophagus 
and oesophageal SpO2 values were compared with those measured using a 
commercial finger pulse oximeter. Measurable PPG traces at red and infrared 
wavelengths were obtained in the oesophagus in all of the 49 patients. (93)  In their 
study, they also found that in five out of the 49 patients, there were one or more 
episodes of at least ten consecutive minutes whereby the commercial finger pulse 
oximeter failed to display any PPG signals and give any readings of oxygen 
saturation. Vasoconstriction and low cardiac output states impede peripheral 
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perfusion and make the detection of any pulsatile signal low to negligible. In contrast 
at these stages, the oesophageal pulse oximeter functioned well throughout those 
periods. Thus, although pulse oximetry is a well and widely established tool for 
monitoring oxygen saturation, there are cases where its use is limited and prone to 
issues of reliability and accuracy. (91)  
 
Pulse oximetry allows continuous non-invasive monitoring of arterial blood oxygen 
saturation. Pulse oximeters estimate arterial blood oxygen saturation by shining light 
at two different wavelengths, red and infrared, through vascular tissue. The pulsatile 
component of the PPG signal is assumed to be due to the arterial blood component. 
The magnitude of the red and infrared signals are sensitive to changes in arterial 
oxygen saturation due to differences in light absorption of oxygenated and 
deoxygenated haemoglobin (Hb) at these two wavelengths. The ratios of these 
amplitudes and the corresponding non-pulsatile PPG components are used to 
estimate the arterial blood oxygen saturation (SpO2). Thus the limitations of pulse 
oximetry are manifested in the fact that it relies on the presence of adequate 
peripheral arterial pulsations, which are detected as PPG signals. Therefore, pulse 
oximetry may not be accurate in patients who have poor peripheral perfusion i.e. 
hypothermic or where pulses are absent or where routine sites for placement of the 
oximeter is not available e.g. burns patients/limb amputees. There have been 
previous studies, which have looked at the use of a oesophageal pulse oximetry 
probe in burns and cardiothoracic patients with good result. (94)(92) 
 
The PPG signal is a potentially valuable indicator of both oesophageal perfusion and 
also general well being. The use of optical fibres to transmit light to and from the 
tissue offers several advantages in sensing applications such as this. Firstly, they 
allow a degree of miniaturisation that is difficult to attain using conventional sensors, 
allowing continuous measurement of oxygenation (or other variables) from remote 
parts of the body.  Mounting the optoelectronic components outside the body reduces 
the risk of electric shock as fibres are typically constructed from glass or plastic 
(both electrical insulators).  Similarly the risk of thermal injury is considerably less 
compared to the case of emitters placed in contact with tissue. Therefore a logical 
next step in this research was to develop a fibreoptic probe that could be used to 
measure oxygen arterial saturation in the oesophagus. There was much discussion 
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amongst myself and the engineers as to size and how the probe could be feasibly 
placed into patients with minimal or no untoward effects. It was decided that using a 
sealed nasogastric tube to encase the fibres would be a very safe and effective option, 
without compromising the potential quality of signals that could be obtained. In 
using the probe, the vascular anatomy of the oesophagus had to be taken into 
consideration. Thus, a relative contraindication to using it would be in patients with 
abnormal oesophageal pathology such as varices. With this in mind, a protocol was 
drafted, ethics approval obtained and patient recruitment began (see Appendix A). 
 
4.2 Aims 
 
The primary aim of this study was to be able to detect signals with this new probe 
whilst using the existing conduit of commonly used naso-gastric tubes available in 
all operating suites. The secondary aim was to analyse and compare results to 
traditional methods of finger pulse oximetry. 
 
4.3 Materials and methods 
 
An oesophageal probe was developed which comprised a cylindrical epoxy moulding 
in which two optical fibres were embedded as shown in Figure 4.1.  
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Figure 4.1 Schematic diagram of the oesophageal probe. Reproduced from (91). 
 
These optical fibres had a larger core diameter of 600 µm (instead of 400 µm as used 
in the other studies) allowing the transmission of more light. The probe was inserted 
into a clean, sealed naso-gastric tube prior to insertion. The fibres used were 
approved for medical use and constructed from biocompatible materials. The naso-
gastric tube has two perforations close to the distal end, which were blocked using a 
silicone bung prior to use (see Figure 4.2). The tube was also marked using a non-
toxic sterile permanent marker at 5 cm intervals to enable accurate positioning in the 
oesophagus.  
 
 
Figure 4.2 Schematic diagram of end of probe. Reproduced from (95). 
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The proximal end of the fibres are connected to a box containing two (red and 
infrared) light sources, a photodetector, power supplies (two 12 V lead acid 
batteries), a circuit board and a computer interface. A block diagram of the system is 
shown in Figure 4.3. The circuit board performs the following functions: 
 
• switching the light sources on and off 
• amplification of the detected light intensity signals 
• filtering the signals to remove interference 
• separation of pulsatile (ac) signals from non-pulsatile (dc) signals 
• synchronisation of computer data acquisition with light source timing. 
 
The instrument box is connected to a data acquisition card (National Instruments 
Inc., Austin, TX, USA) installed in the PCMCIA slot of a notebook computer. 
 
 
 
 
Figure 4.3 Block diagram of the measurement system. Adapted from (96). 
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We obtained approval from the Research Ethics Committee as well as the Medicines 
and Healthcare Products Regulatory Agency (MHRA) to study 20 patients using the 
probe.   Patients undergoing minor general surgical procedures requiring tracheal 
intubation and mechanical ventilation were deemed suitable for this study. Adult 
patients aged (18 to 70) and classified as ‘low risk’ by the American Society of 
Anesthesiologists (ASA 1 to 3) were identified from the elective operating lists at 
Barts Health NHS Trust. Any patients in whom we anticipated difficulty with probe 
placement were excluded. Other patients that would be excluded were those of 
known difficult airway anatomy, any abnormality of the upper gastrointestinal tract, 
clotting disorders, history of oesophageal varices, hiatus hernia, any oesophageal 
pathology, previous gastric surgery, and pregnant women. After suitable patients 
were identified, full written informed consent was sought prior to their scheduled 
surgery. 
 
After induction of anaesthesia and immediately after tracheal intubation, the probe 
contained within a sterile naso-gastric tube was inserted into the oesophagus by the 
anaesthetist, via the patient’s mouth, under direct vision with a laryngoscope. The tip 
of the probe was placed at a depth of 35 cm in the oesophagus as measured from the 
front incisors. Once the probe was in position, the light sources were switched on and 
signals recorded for 100 seconds. The probe was then withdrawn 5 cm at a time and 
signals recorded for a further 100 seconds at each position until the probe was at a 
depth of 15 cm. The arterial oxygen saturation was measured using a commercial 
finger pulse oximeter (Datex-Ohmeda, Helsinki, Finland). The lungs were 
mechanically ventilated throughout this monitoring period. Peak airway pressures 
were recorded, as well as blood pressure readings during the measurement period. 
The probe was removed at the end of the measurement period, before the patient was 
moved from the anaesthetic room to the operating theatre, and surgery commenced. 
Each patient was reviewed post-operatively, with no documented adverse events.  
 
4.4 Results 
 
20 patients were recruited to the study. In all cases, the oesophageal probe passed 
easily into the oesophagus with no resistance and PPG signals obtained without any 
major issues. Signals were successfully obtained from 19 patients, with the one 
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failure attributable to poor signal quality. The patient demographics are shown below 
in Table 4.1.  
 
Male:Female 7:13 
Mean age (±SD) 43.3yrs (13.6) 
Mean height (±SD) 167.4 cm (9.3) 
Mean weight (±SD) 74.9kg (13.0) 
Mean BMI (±SD) 26.7 (4.1) 
Table 4.1 Patient demographics. 
 
The PPG (AC signal) was separated from the total intensity (AC+DC) signal using 
filters incorporated into the measurement circuitry.  The PPG signal was normalised 
by dividing the signal by the simultaneously recorded AC+DC signal.  This has the 
effect of standardising the red and infrared signals levels, eliminating any differences 
in signal intensity caused by differences in brightness of the light sources, differences 
in sensitivity of the photodetctor to each wavelength and other effects.  Also any 
slowly changing variations in any of these factors are eliminated. The peak-to-peak 
amplitudes of the normalised PPG signals were calculated for each heartbeat using a 
peak and valley detection algorithm incorporated into a LabVIEW virtual instrument. 
 
Figure 4.4 below shows typical PPG waveforms obtained over a 30-second period at 
various depths. 
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Figure 4.4 Showing 30-second samples of the normalised AC PPG waveforms obtained at 
each measurement depth. Reproduced from (96). 
 
Figure 4.5 shows a bar graph of the mean (±SD) of the normalised AC PPG 
amplitudes at red and infrared wavelengths at the five monitoring depths for all 
patients. The AC signals in the mid to lower oesophagus (depths of 20 cm or greater) 
have significantly larger mean amplitudes at both wavelengths than those in the 
upper oesophagus (15 cm). The maximum mean oesophageal amplitude for each 
wavelength occurs at the depth of 20 cm. 
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Figure 4.5 Bar graph of the mean (±SD) of the normalised AC PPG amplitudes at red and 
infrared wavelengths at the five monitoring depths for all patients. Reproduced from (96). 
 
In this model, any movement of the probe, caused a change in amplitude of DC 
signal, with small amount of modulation from the respiratory frequency. There was 
significant change in amplitude of the AC signal with depth of the probe, especially 
at greater depths. The overall morphology of the PPG signal varied greatly with the 
depth of the probe. 
 
The ratio of ratios was used to calculate the oesophageal arterial oxygen saturation 
(SoO2), using the equation SoO2 = 110 – 25RR. The maximum mean amplitude for 
both wavelengths was at a depth of 20 cm. The amplitudes of the red and infrared 
normalised PPG signals obtained at 15 cm were significantly smaller (P<0.001) than 
those obtained at all other depths, using a paired Student’s t-test.  There was no 
significant difference between amplitudes at other adjacent depths (i.e. 20–25 cm, 
25–30 cm and 30–35 cm).(96) 
 
The mean red and infrared signals at each depth were calculated using the ratio of 
ratios. To compare the signals between the patients, the ‘best depth’ (i.e. depth at 
which signals were best for each individual patient) was chosen. The mean ratio of 
ratios for each patient was also calculated from the PPG amplitudes. Table 4.2 shows 
several variables derived from the signals for each patient obtained at what was the 
‘best depth’. From the results, there is quite a great degree of variability in the 
amplitudes of the variables.  
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Pat. 
# 
‘Best’ 
depth 
(cm) 
Normalized PPG amplitudes Mean 
SoO2 
(%) 
Red 
(/10-3) 
Infrared 
 (/10-3) 
1 30 10.7 14.0 90.9 
2 20 11.6 16.8 92.7 
3 30 1.03 2.74 100.6 
4 25 7.14 6.86 84.0 
5 25 16.5 24.8 93.4 
6 25 4.94 12.4 100.0 
7 30 3.72 9.33 100.0 
8 25 4.82 6.52 91.5 
9 20 3.22 5.58 95.6 
10 35 2.68 4.16 93.9 
11 30 4.85 8.21 95.2 
12 35 3.98 5.51 91.9 
13 30 3.73 7.80 98.0 
14 30 4.14 6.68 94.5 
15 25 2.57 3.91 93.6 
16 25 3.66 6.78 96.5 
17 20 5.59 8.59 93.7 
18 25 6.08 7.95 90.9 
20 25 1.67 1.99 89.0 
Table 4.2 Table of PPG signals obtained at the ‘best depth’. Where SoO2 is the oxygen 
saturation from the oesophageal probe. Adapted from (96). 
 
The signals from the mid-oesophagus had the best signals. The mean value of 
oxygen saturation for all 19 patients was 94% (± 4.0%). The oxygen saturation 
recorded by the standard commercial pulse oximeter probe, was in the range of 98–
100% in all 19 patients.  
 
At the time of insertion of the oesophageal probe as well as when the measurements 
were recorded, blood pressure (BP) and peak airway pressures (PP) were also noted. 
Further analysis of the data taken from the 20 cm depths was performed, since this 
depth is favourable by virtue of the fact that for the group of patients as a whole, the 
greatest mean signal intensity was obtained at this depth. At this depth, the 
normalised PPG amplitude was plotted against arterial pulse pressure, mean arterial 
pressure (MAP), arterial systolic pressure, and arterial diastolic pressure. Figure 4.6 
shows the graph of normalised PPG amplitude versus average arterial pulse pressure 
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over a five-minute period, the equation of the line was calculated by least squares 
regression giving a correlation coefficient 0.766. Similarly, Figure 4.7 shows the 
graph of normalised PPG amplitude versus mean arterial pressure, with a correlation 
coefficient of 0.504; Figure 4.8 shows the graph of normalised PPG amplitude versus 
arterial systolic pressure, with a correlation coefficient of 0.644; Figure 4.9 is the 
graph of normalised PPG amplitude versus arterial diastolic pressure, with a 
correlation coefficient of 0.292. From the four graphs, one can see that correlation is 
best when plotted against arterial pulse pressure (systolic minus diastolic pressure).  
 
A Bland-Altman (96) comparison (Figure 4.10) was performed between oesophageal 
oxygen saturation (SoO2) and oxygen saturation via finger pulse oximetry (SpO2), 
measured at best depth. The horizontal lines show mean ±2SD, enclosing 95% of 
points. The lower the SoO2, the bigger the negative difference in readings as finger 
oxygen saturation was always greater than 97%. Finally, the difference between 
SoO2 and SpO2 was also plotted against the average peak airway pressure in Figure 
4.11. There is a general trend for subjects ventilated at higher peak airway pressures 
to exhibit lower oesophageal oxygen saturation values compared to those measured 
from the finger. 
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Figure 4.6 Plot of normalised PPG amplitude versus arterial pulse pressure; correlation 
coefficient 0.766. 
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Figure 4.7 Plot of normalised PPG amplitude versus mean arterial pressure (MAP); 
correlation coefficient 0.504. 
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Figure 4.8 Plot of normalised PPG amplitude versus arterial systolic pressure; correlation 
coefficient 0.644. 
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Figure 4.9 Plot of normalised PPG amplitude versus arterial diastolic pressure; correlation 
coefficient 0.292. 
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Figure 4.10 Bland-Altman comparison of oesophageal oxygen (SoO2) and oxygen saturation 
readings (SpO2). 
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Figure 4.11 Graph showing the relationship between peak airway pressure and SoO2, SpO2 
difference. 
 
4.5 Discussion 
 
This demonstrated that PPG signals could be reliably recorded from the oesophagus. 
The amplitude and quality of the signals depended on the depth of the probe. In this 
study, the greatest amplitude (i.e. best quality) signals were at about 20 to 30 cm 
from the teeth. In a different study by Kyriacou et al, using a non-fibre optic probe, 
they found similarly good readings at the same depth. One reason could be that at 
this depth, the locality of the descending aorta is in close proximity to the 
oesophagus and hence good amplitude PPG from this big pulsatile structure may 
have contributed to this.  
 
In this study the value of the mean oxygen saturation of 94 ± 4.0% was lower than 
that recorded from the finger using the commercial pulse oximeter. The slight 
negative bias may be attributable to the use of an algorithim for calculation of the 
SpO2 which was developed from experimental measurements using transmittance 
mode probes on a different measurement site (the finger rather than the oesophagus). 
There may also have been inaccuracies from mechanical ventilation with the probe in 
close proximity to the lungs and the heart. It has been observed that PPG signals are 
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sensitive to the movement of the tips of the fibres relative to the surface of tissues as 
well as movement of the fibres themselves. It may also be supposed that the induced 
movement modulation, would be similar in magnitude for both wavelengths, so the 
calculated ratio-of-ratios (normally <1 for arterial blood) would be higher in the case 
than with no movement. This would very likely result in underestimation of the 
measured oxygen saturation. 
 
The graphs drawn in Figures 4.6 to 4.9 show that there is a possible correlation 
between the amplitude of signal obtained and blood pressure; in particular the 
correlation was strongest when compared against arterial pulse pressure (correlation 
coefficient of 0.766). This finding is not surprising as good PPG signals are 
dependent on adequate circulation and pulsatile blood flow. The differences between 
SoO2 and SpO2 measured at best depths against the mean of the two measurements 
(Bland-Altman plot) in Figure 4.10 showed small bias between the two methods and 
suggests that the oesophageal probe could be an accurate substitute for finger pulse 
oximetry. The graph shown in Figure 4.11 illustrated that airway pressure had an 
effect on PPG readings obtained. It showed that the higher the peak pressure in the 
airways the lower the readings obtained. This is not unexpected, as an increase in 
intrathoracic pressure would cause a decrease in blood flow temporarily in the 
thoracic part of the oesophagus and affecting blood flow, in particular venous 
compression within the oesophageal wall that occurs during the course of positive 
pressure ventilation. Furthermore, the volume of venous blood is likely to be affected 
by the airway pressure so periodic modulation of the venous blood would have an 
effect on the relative intensity of red and infrared light detected by the probe.  This in 
turn could affect the calculated oxygen saturation value.  
 
The principle underpinning pulse oximetry is the assumption that the ‘pulsatile 
component’ is solely comprised of the signal from blood in the arterial vasculature 
(i.e. the absorption increases as the path length increases during expansion of the 
arterial vessel), and that the venous component is static. In reality, this may not 
always be the case. Here we can see that venous blood is effectively confused with 
arterial blood due to its variable volume, plausibly leading to underestimation of the 
oesophageal oxygen saturation. This effect is greatest at high airway pressure as 
might well be expected. 
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The aim of seeing whether this innovative fibreoptic probe could be used to obtain 
useful signals was shown to be a success. However, in this study, we compared this 
to the finger pulse oximeter instead of measuring against arterial and venous blood 
oxygen saturations, as this was not deemed appropriate in this group of patients. 
Certainly from this pilot study, the results are promising and further clinical studies 
comparing against CO-oximetry would be warranted.   
 
4.6 Conclusions 
 
20 patients were recruited into this study with no untoward events. 19 results were 
deemed suitable for use in the final analysis. Good signals were obtained from 19 
patients allowing comparison between values obtained from the fibreoptic probe with 
commercial pulse oximetry. There appeared to be a discrepancy in results by about 
4% either way compared to the commercial probe. There was a strong correlation 
between PPG amplitude and arterial pulse pressure. A further study comparing the 
results with arterial oxygen saturation would be needed in order to ascertain the true 
accuracy of the probe. 
  92 
CHAPTER FIVE–PHOTOPLETHYSMOGRAPHIC SIGNALS OBTAINED 
FROM THE ABDOMINAL CAVITY 
 
5.1 Introduction 
 
In anaesthesia and critical care, there remains an area of unmet need– the ability to 
adequately and accurately measure splanchnic perfusion. In critical care and under 
anaesthesia, where mean arterial blood pressure and hence organ perfusion is 
lowered secondary to drugs given or primary pathology of the patient, the adequacy 
of perfusion of the gut and liver is likely of major importance in those that are 
critically ill. This is because inadequate perfusion could be associated with hepatic 
and gut injury and dysfunction and consequently increased patient morbidity and 
mortality. 
 
The small intestine is the longest part of the alimentary tract and extends from the 
pylorus of the stomach to the ileocecal junction. It is divided into three parts: the 
duodenum, jejunum and ileum. The blood supply of the duodenum is from a branch 
of the gastroduodenal artery. The pancreaticodueodenal vein drains into the portal 
vein whilst the inferior vein joins the superior mesenteric vein. The lymphatic vessels 
follow the arteries and drain upward via pancreaticoduodenal nodes to the coeliac 
nodes and also down towards the superior mesenteric nodes. The jejunum and ileum 
receive their arterial blood supply from branches of the superior mesenteric artery. 
The intestinal branches arise from the left side of the artery and run in the mesentery 
to reach the gut. They form an anastomosis with one another, with the lowest part of 
the ileum supplied by the ileocolic artery. The veins of the jejunum and ileum 
correspond to the branches of the superior mesenteric artery and drain into the 
superior mesenteric vein. The lymphatic drainage is via the mesenteric nodes. (96) 
 
The large intestine extends from the ileum to the anus with its primary function to 
absorb water and electrolytes and store undigested material till it is expelled as 
faeces. The blood supply of different parts of the gastrointestinal tract is related to 
the position in the abdominal cavity but is all essentially branches derived from the 
mesenteric arteries. One of the most important accessory organs of the 
gastrointestinal tract is the liver, which is also the largest known gland in the human 
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body. It has many functions including metabolism of fat, protein and carbohydrates; 
secretion of bile; filtration of bacteria and foreign particles in the bloodstream. It lies 
in contact with the abdominal part of the oesophagus, stomach, duodenum, right 
kidney and the gall bladder. It is tradition to divide the liver into the right and left 
lobes. The right and left branches of the hepatic artery and portal vein, right and left 
hepatic ducts are distributed to the right and left lobes of the liver respectively. The 
liver is completely surrounded by a fibrous capsule and is made up of liver lobules. 
The central vein of each lobule is a tributary of the hepatic veins. There are spaces 
between each lobule called the portal canals–within which lie branches of the hepatic 
artery, portal vein and a tributary of a bile duct, all collectively forming a portal triad. 
The arterial and venous blood passes between the liver cells by means of sinusoids 
and drains into the central vein. The hepatic artery, a branch of the coeliac artery, 
supplies the liver via its right and left terminal branches. The portal vein also divides 
into the left and right terminal branches behind the arteries and emerges from the 
posterior surface of the liver draining into the inferior vena cava. The blood vessels 
that bring blood to the liver are the hepatic artery and portal vein. The hepatic artery 
brings oxygenated blood to the liver while the portal vein brings venous blood rich in 
the products of digestion. The arterial and venous blood is conducted to the central 
vein of each liver lobule by the liver sinusoids, draining into the right and left hepatic 
veins. These leave the posterior surface of the liver and open directly into the inferior 
vena cava. Large amounts of lymph are also produced by the liver (about one-third to 
one-half of total body production), which then leave the liver and enter lymph nodes 
in the porta hepatis. (97) 
 
There are several risk factors, which increase the likelihood of inadequate organ 
perfusion. Certain surgical procedures, such as cardio-pulmonary bypass surgery or 
abdominal aortic aneurysm surgery, peri-operative hypotensive episodes, the use of 
vasopressors either directly or indirectly affects the adequacy of end organ perfusion. 
Perfusion deficits remain a real risk with any form of prolonged hypotensive 
episodes, which can lead to organ ischaemia, infraction and death. Whilst there 
remains much controversy over the actual mechanisms where by some of the above 
procedures, such as cardio-pulmonary bypass surgery, have on affecting 
gastrointestinal function, there still remains no direct means of measuring the 
adequacy of end organ perfusion. In cardio-pulmonary bypass surgery, although the 
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incidence of gastrointestinal complications is relatively low (0.3% to 3%), they are 
associated with a high mortality rate (13% to 63%). It is widely accepted that global 
measurements of oxygen delivery, consumption and extraction do not provide 
reliable information on the adequacy of tissue oxygenation.  
 
Gastric mucosal tonometry has been used for assessing splanchnic perfusion in 
various clinical settings. (98) This involves the indirect measurement of gastric 
mucosal pH and is a minimally invasive way of assessing the adequacy of tissue 
oxygenation. (98) Acid-base balance in tissue is determined primarily by the balance 
between the protons released during the release of energy by ATP hydrolysis and 
consumption by the resynthesis of ATP during oxidative phosphorylation. When the 
rate of oxygen delivery cannot meet the need for resynthesis of ATP in response to 
the energy requirements of the tissues, the rate of ATP hydrolysis exceeds the rate of 
synthesis and the pH decreases in proportion with the degree of unreversed ATP 
hydrolysis or dysoxia present. Thus, the measurement of gastric intramucosal pH 
gives a measure of tissue acid-base balance in a region of the body that is among the 
first to develop dysoxia in shock. The duration and degree of these episodes of 
dysoxia can be quite frequent and sustained in cases of shock in critically ill patients, 
despite the patients giving the appearance of being adequately resuscitated. During 
these episodes gastric mucosal acidosis are highly sensitive measures of the risk of 
developing “leaky gut “and its consequences, namely translocation, cytokine release, 
sepsis, multi-organ dysfunction and failure, and ultimately death. Gastric tonometry 
works by providing a tangible index of suspicion to clinicians of the adequacy of 
tissue oxygenation in one of the first parts of the body to exhibit dysoxia in shock. 
Measurement of gastric intramucosal pH is one way of being able to monitor and 
obtain readings that could provide an early warning system to the onset of tissue 
dysoxia and the opportunity to intervene early on to prevent further damage. 
Measurement of the regional gastric carbon dioxide tension as well as calculation of 
the difference between intramucosal and arterial carbon dioxide tension may give 
additional information about blood flow in the splanchnic area. 
 
There are other blood tests or markers that, when used in combination with gastric 
tonometry, can give a rough indication of splanchnic function. Tests such as gamma 
glutamyl transpeptidase enzymes, which become elevated in liver disease, or 
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pancreatitis associated protein (PAP), which is a non-enzymatic secretory protein 
that becomes markedly elevated in the acute phase of pancreatitis. However these 
tests are unable to give an idea of splanchnic function or how well perfused the 
organs of the gastrointestinal tract are.  
 
Whilst clinical biochemistry laboratory blood assays looking at body urea, creatinine, 
electrolytes, can give a rough non-specific estimation of how well the kidneys and 
liver may be functioning, it allows no indication of actual perfusion and viability of 
individual organs in the body. Conventional liver function tests such as serum 
albumin (Alb), alkaline phosphatase (ALP), alanine amino transaminase (ALT) and 
bilirubin can give an idea of how well the liver is functioning, and also an indication 
of the extent of any liver damage. However, an overall idea of perfusion of the organ 
cannot be ascertained just from liver function tests. Unfortunately, when blood test 
results become severely deranged, end organ damage is by then usually irreversible. 
 
If one were able to continuously monitor splanchnic perfusion accurately, then any 
early tissue damage secondary to hypoxia could be picked up early and the 
appropriate treatment given prior to irreversible end organ damage. Whilst pulse 
oximetry has become a widely accepted method for monitoring arterial blood oxygen 
saturation, it has been tested experimentally to access intestinal oxygenation and 
hence viability in animal as well as human studies.(99) The preliminary results have 
shown to be promising with sensitive consistent readings given for detecting 
intestinal ischaemia. Currently, there are no commercially available pulse oximeter 
probes specifically designed for use to measure continuous oxygen saturation in the 
splanchnic region. This led to discussion into development of a probe capable of 
measuring oxygen saturation of the organs of the abdominal cavity, in a simple, 
quick fashion with minimal or no trauma to the patient. In the following study, a new 
avenue in fibreoptic technology will be explored to see whether a newly developed 
probe would be able to obtain adequate, clinically useful signals in terms of 
monitoring splanchnic perfusion in humans. The successful signal acquisition in the 
preceding studies provided the rationale to develop a probe, again based on fibreoptic 
technology, in a new study to see whether clinically meaningful PPG signals could 
be obtained from the external surface of abdominal organs during a laparotomy. 
(100)  
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5.2 Aims 
 
The primary aim of this study was to see whether this newly developed probe could 
be used in the monitoring of arterial pulsation and oxygen saturation from the surface 
of abdominal  organs. If successful, this would justify the development of a miniature 
monitoring probe for a larger evaluation study. The secondary aim of the study was 
to compare the PPG measurements obtained, from the probe which would be placed 
on various organs in the abdominal cavity, and to correlate this with finger pulse 
oximetry and ECG signals (see Appendix A). 
 
5.3 Materials and methods 
 
The fibreoptic probe was constructed with two fibreoptic leads. Like in the previous 
study, one cable was a receiving cable and the other a transmitting one. The fibres 
were connected to a processing system (electronic circuit board enclosed in a box) 
shown in figure 5.1. The circuit board comprised all optical components (light 
sources and photo detector) and electronic circuits used to drive the light sources and 
process the incoming signal from the tissues via the fibre. The processing system is 
battery operated (two 9V PP3 batteries). The abdominal pulse signals are sent to a 
computer. Software was written to display on the screen of the computer all of the 
signals acquired from the patient. The end of the probe was embedded in epoxy and 
inserted into a disposable sterile plastic sheath prior to it being used on a patient. 
Figures 5.2 and 5.3 show a photo of the probe close up from different views. 
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Figure 5.1 Photograph of the electronic circuit enclosed in a box. 
 
 
 
 
Figure 5.2 Photograph of the probe with a ruler for scale. 
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Figure 5.3 Photograph of the probe from the front showing the transmitting and receiving 
fibres. 
 
A Lead II ECG channel was also included in the overall system to monitor the R 
waves on the ECG, which were used as a reference point for the splanchnic and 
finger PPG signals. Red and infrared PPG signals, red and infrared DC signals and 
ECG signals are digitised at a rate of 200 Hz by the National Instruments data 
acquisition card which was connected to a Toshiba laptop computer. These signals 
were then further processed using the LabVIEW system as in the previous studies. 
The acquired signals were filtered to remove any digitisation noise and displayed on 
the front panel of the virtual instrument.  Finally, the signals were grouped together, 
converted into spreadsheet format and saved to a text file for post-analysis. Full 
ethics committee approval was obtained for this study. Patients suitable for 
recruitment into the study were those over the age of 18 years who were undergoing 
an elective laparotomy. Full informed consent was obtained from all patients. In 
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terms of data collection, all analogous data from the routine monitoring equipment 
was used i.e. ECG and finger pulse oximetry. Red and infrared PPG and DC signals 
from the surfaces of the organs, calculated arterial oxygen saturation from the organs 
and arterial oxygen saturation from a finger probe, as well as ECG was measured and 
recorded in a notebook computer. A block diagram of the system is shown below in 
Figure 5.4.  
 
Figure 5.4 Block diagram of the PPG monitoring system adapted from (101) 
 
In total 20 adult patients were recruited into the study, from elective operating lists 
within Barts Health NHS Trust. There were four male and sixteen female patients 
who underwent laparotomies for a mixture of general surgical, gynaecological-
oncological and upper gastrointestinal surgical procedures.  
 
After the induction of general anaesthesia, the patients were intubated and the lungs 
mechanically ventilated. Anaesthesia was maintained with inhalational isoflurane in 
a 1:2 mixture of oxygen and nitrous oxide. In addition to the standard monitoring 
employed for all patients undergoing general anaesthesia i.e. pulse oximeter, ECG, 
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and blood pressure monitoring, an additional set of ECG leads was attached for the 
purposes of the study. The fibreoptic peripheral PPG sensor was also placed on the 
finger of the patient. The fibreoptic splanchnic probe was sheathed by a sterile 
transparent cover and secured in place. At an appropriate time during the surgery, the 
fibreoptic probe was passed to the operating surgeon, and applied with minimal 
pressure, onto the surfaces of each available splanchnic organ, in such a way that the 
emitted light from the probe was reflected from the surfaces. During the 
measurement period, overhead operating lights were switched off to minimise any 
interference with the PPG sensor. During the measurement period, simultaneous AC 
and DC splanchnic PPGs as well as AC and DC peripheral PPGs and ECG signals 
were recorded for approximately two minutes at each different splanchnic site from 
which recordings were being taken. At the same time the PPG readings were taken, 
oxygen saturation readings from a peripheral commercial pulse oximeter as well as 
heart rate and non-invasive blood pressure readings were also recorded from the 
monitors in the operating theatres.  
 
5.4 Results 
 
In total 20 patients were recruited, but three patients were excluded from the final 
analysis, due to the peripheral fibreoptic probe becoming detached from the finger in 
one, and in the other two, the duration of the monitoring period was too short to 
acquire suitable signals for analysis. Patient demographics for all patients are shown 
below in table 5.1. 
 
Male:Female 3:17 
Mean age (±SD) 52.9 years (11.4) 
Mean height (±SD) 165.9 cm (9.8) 
Mean weight (±SD) 81.2 kg (16.5) 
Mean BMI (±SD) 29.3 (5.0) 
Table 5.1 Patient demographics 
 
In total, 41 splanchnic sites were investigated: there were 17 measurements taken 
from small bowel, 14 from large bowel, five from the liver and five from the 
stomach. Good quality PPG signals were obtained from all the sites investigated. The 
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acquired traces were in sync with the obtained peripheral PPG signal as well as the 
ECG signal. This thus implied that the measured signal from the small bowel 
represents the movement of the cardiac pulse throughout the splanchnic tissue. There 
were some artefacts possibly from the lungs being ventilated mechanically or 
movement by the hand of the surgeon holding the probe, but this had no significant 
effect on the readings obtained. For each splanchnic sited that was used, mean AC 
and DC amplitudes were calculated for the red and infrared signals by averaging the 
PPG amplitudes over approximately two minutes of data recording. The 
corresponding mean AC and DC amplitudes for the red and infrared peripheral 
signals were also calculated. 
 
A mean of the means splanchnic and AC and DC signals for each site were 
calculated for each of the four sites as well as the peripheral readings. In general the 
mean of the means AC amplitude from the large and small bowel were similar, these 
were smaller than the mean of the means AC amplitude obtained from the liver, but 
bigger than the mean of the means AC amplitude from the stomach and about four 
times bigger than that obtained from the peripheral PPG signals. There was good 
correlation of the mean of the means DC amplitudes from all four splanchnic sites – 
small bowel, large bowel, liver, stomach and the peripheral sites. However, the DC 
amplitudes were all approximately seven times larger than that obtained from the 
periphery. Figure 5.5 and Figure 5.6 show a sample PPG trace, displayed alongside 
the ECG trace, obtained from signals taken from the large and small bowel 
respectively. The traces represent good quality PPG signals. 
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Figure 5.5 AC PPG signals from the large bowel. Adapted from (102). 
 
 
Figure 5.6 AC PPG signals from small bowel. Adapted from (103). 
 
In order to access the ability to estimate oxygen saturation, bearing in mind that this 
was an uncalibrated system, preliminary SpO2 values were estimated for each site 
under investigation, in order to see how feasible it would be to estimate blood 
oxygen saturation. For each two-minute period of monitoring, mean splanchnic and 
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peripheral SpO2 values were estimated by obtaining an average of SpO2 values over 
two minutes of data. The values obtained from the commercial pulse oximeter, over 
the two-minute period, were also averaged to obtain a mean value.  
 
The mean of the means SpO2 value obtained from the peripheral fibreoptic probe 
(97.94%) agreed well with the values obtained from the commercial pulse oximeter 
(97.88%). With respect to the SpO2 values obtained from the large bowel (97.14%) 
and small bowel (97.41%), these were in good agreement with those obtained 
peripherally. The mean SpO2 obtained from the stomach was 95.80%, and the mean 
SpO2 obtained from the liver was 100.60%.  
 
5.5 Discussion 
 
From this pilot study, we managed to obtain good quality PPG signals from all the 
splanchnic sites under investigation. The estimation of SpO2 involves calculating 
the amount of light transmitted through the tissues and hence despite the varying 
signals, SpO2 can be calculated from these sites. There were a few artefacts 
attributable to either ventilator movements or to the personnel holding the probe, 
but overall, the signals showed good depth, strength and reliability. When looking 
at the mean of the means of both the AC and DC signals at the different sites the 
readings were taken from, there was found to be differences in amplitude. For 
example for the large bowel and small bowel there was found to be a significant 
difference between the signals obtained from these sites compared to those 
obtained from the periphery. The magnitude of these differences was more than 
three times larger than those obtained from the peripheral probe. This essential 
difference is not unexpected as there is a great difference in the vascular supply of 
both areas in question. The tissue overlying the peripheral skin consists of a thick 
epithelium on the outermost, superficial surface that contains no blood vessels. 
 
In comparison, the surface lining the large and small intestines is a thin serosal 
mucosa, which has secretory functions and an underlying connective tissue layer. 
The mucosal epithelial lining is extremely thin and porous (less than 100 
micrometres in thickness) and hence the distance of the blood vessels is much 
closer to where the probe would rest compared to when taking measurements from 
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the finger. There is also a greater volume of blood, pulsating throughout the 
splanchnic sites compared to at the finger and hence the expected larger signals 
obtained at those sites compared to the periphery. There is also less chance of any 
light being absorbed by the thicker epidermal tissue on the finger compared to in 
the large and small intestinal sites. Looking at the signals obtained from the 
stomach, these were smaller in amplitude compared to the other splanchnic sites, 
but still larger than those obtained from the peripheral probe. These results again 
suggest that the difference in tissue and vascular supply between the two sites 
account for the difference in amplitude of signals obtained.  
 
Similarly for the liver, the difference in amplitude of the signals obtained were 
again much larger than that obtained from the periphery due to the vascular nature 
of the liver. It must be borne in mind the anatomy of the liver is different from the 
other organs as described in detail in the introduction to this chapter. The hepatic 
arteries supply arterial blood to the liver with oxygen being supplied from both the 
hepatic portal veins as well as the arteries. Blood flows through the sinusoids and 
drains into the central veins of each lobule. The central veins merge into the 
hepatic veins which exit the liver into the inferior vena cava. 
 
However, it appeared likely, bearing in mind the small sample size of five patients, 
that there may be an underlying difference between the PPG signals obtained from 
the liver compared to the other splanchnic sites. However, there was also a 
difference in the SpO2 values obtained from the liver compared to the commercial 
pulse oximeter. This could be due to the vascular nature of the blood supply to the 
liver. It has to be noted that the calculations were made with the small sample size 
of five patients. There were no complications associated with use of this probe in 
this patient group. 
 
5.6 Conclusions 
 
This was a pilot study to evaluate a newly developed fibreoptic probe designed for 
the purpose of obtaining signals to allow the calculation of arterial oxygen 
saturation. 20 patients in total were recruited for this study with the signals from 17 
patients included in the final analysis. In all 17 patients, good quality signals were 
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obtained from all of them. PPG signals from splanchnic organs, peripheral PPGs as 
well as ECGs were noted for the monitoring period. Values from commercial pulse 
oximetry were noted during the monitoring period. In all cases, the preliminary  
SpO2 values from each splanchnic site showed a good correlation with the values 
obtained from the peripheral fibreoptic probe as well as the commercial pulse 
oximeter. There was a big difference in PPG amplitudes obtained from the 
splanchnic sites compared to the corresponding peripheral sites in each of the 
subjects. This was likely due to the difference in vascular component of the 
splanchnic tissues compared to the peripheral tissues affecting transmission of light 
as well as amount of blood flow through the tissues. The estimation of SpO2 from 
the splanchnic sites showed a good correlation with the values obtained both from 
the peripheral probe as well as the commercial pulse oximeter. (104) The sample 
size from the liver and stomach were too small to make more conclusive 
calculations. Further larger studies are needed in order to further evaluate the 
usefulness of this probe. 
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CHAPTER SIX–OVERALL SUMMARY AND CONCLUSIONS 
 
The overall aim was the evaluation of innovative fibreoptic probes specifically 
constructed for the purposes of being able to measure PPG signals from different 
regions in the human body. These were used for the first time in the clinical 
population, and showed good quality viable signals yielding positive results. A total 
of 47 patients were recruited, of which 44 yielded good quality signals. The four that 
were excluded from subsequent signal processing and analysis were because of poor 
signal quality [n=1], or inadequate time to record [n=2], or the probe becoming 
detached from finger [n=1]. None of the patients suffered any untoward side effect 
attributable to the research studies. 
 
The aim of my research was to clinically evaluate novel methods of measuring 
oxygen saturation in human tissues using photoplethysmographic fibreoptic 
technology. In conjunction with biomedical engineers at City University, innovative 
fibreoptic probes were designed and constructed with this in mind i.e. to measure 
oxygen saturation at various sites in the body. This is of relevance to particular 
clinical patient populations, in whom there is an unmet need in patient monitoring. A 
series of pilot studies were proposed and research ethics approval sought in order to 
carry out research on the patient population using the various probes. 
 
Research ethics approval was successfully sought for all of the clinical studies with 
modified probes and materials used in each of them, along with MHRA approval as 
appropriate. These were innovative new probes designed specifically in each of the 
studies to be able to obtain the potentially useful signals needed for final analysis. 
These were all pilot studies done in carefully selected patient population groups.  
 
The expected recruitment number in the studies of the oesophageal probe and the 
splanchnic probe were achieved [n=20] in each. For a pilot study, and with statistical 
advice, this was felt to be an adequate number in order to make the preliminary 
assessments on each of the probes. In the study evaluating the fibreoptic probe that 
was used to measure brain oxygen saturation in elective neurosurgical patients, a 
total of six patients were recruited. Whilst the initial target of ten patients for this 
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study was not met due to logistical reasons, the signals obtained from all six were of 
good quality and consistency to be able to make an informed assessment of the 
potential usefulness of the results obtained in that clinical group of patients. The 
implementation and results were entirely novel, in that this was the first time, that red 
and infrared PPG signals have been obtained directly from human tissue (brain) 
using fibreoptic technology. Technically these measurements validated the design, 
construction and materials used, in terms of fibre type, inter-fibre separation, LED 
drives current and depth of penetration. There were difficulties in assessing whether 
some of the results were due to arterial or venous pulsation in the brain, which could 
lead to potential difficulties in the future with accuracy or methodology of true 
arterial measurements. 
 
With respect to the usefulness of the probe in the longer term on patients with brain 
pathology on the intensive care unit, only one patient had been recruited thus far. 
This one patient had suffered an intracerebral haematoma. It would have been good 
to have more patients with different brain pathologies in order to compare and 
contrast any results. Indeed, it would have been useful to have recruited a few trauma 
patients, with head injuries, in order to relate the PPG signals to ICP readings, that 
would have been obtained, and to the eventual outcome in such patients. It would 
have been ideal also to have been able to obtain signals over a more prolonged period 
of time i.e. to have kept the fibreoptic probe in situ in a patient with an intracranial 
bolt present and to see whether signals of good quality could be obtained over a 
prolonged period of time and whether it would have been feasible to have kept the 
probe in situ for a period of 48 hours. There were problems with the intracranial 
probe in terms of interference from movement artefacts – either due to external 
factors such as patient or staff movement or interference from diathermy in the 
operating room, the stealth machine and ventilatory artefacts. In terms of probe 
materials and construction, it was a robust model that was easy to use and handle. 
Due to the small sample size of the pilot study, the accuracy of readings obtained 
cannot be further commented on.  
 
Nevertheless, the initial readings were promising and warrant further study to allow a 
more detailed analysis of the technique and to see if it can offer advantages over 
current monitoring technology. It would be interesting to see how future results 
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would compare with readings from jugular bulb oximetry, though this would give an 
indication of global oxygen saturation, rather than local oxygen saturation as 
measured by the fibreoptic probe. One potential source of error, was if a blood clot 
was surrounding the tip of the fibreoptic probe, this could lead potentially to over or 
more likely under readings of oxygen saturation. The initial successful signal 
acquisition using fibreoptic technology provided the justification for the development 
and clinical study of probes using this same technology platform, to measure PPG 
signals in the oesophagus and in the abdomen. 
 
Firstly, the fibreoptic oesophageal probe was evaluated. A total of 20 patients were 
recruited of whom 19 yielded signals that were suitable for final analysis. The study 
was similar in design to that using a miniaturised oesophageal probe. This new probe 
had the advantage that no electrical components were placed internally in the patient.  
Good quality signals were obtained and the derived SpO2 results were comparable 
with peripheral pulse oximetry readings. However, the gold standard of CO-oximetry 
was not available for use in this pilot study in order to make a better prediction of 
how accurate the correlation would be to arterial oxygen saturation. The probe is a 
robust model though it is prone to movement artefacts. The ease of use, in terms of 
insertion into the oesophagus was smooth and without any complications. In the 
anaesthetised patient, it could remain in situ for prolonged periods though this was 
not looked at in the study. One of the potential usefulness of such a probe, is of 
course for use in patients where peripheral pulse oximetry would be inaccurate or not 
possible for example in patients with hypothermia or burns. Further studies looking 
at its use in such a patient group, with comparisons to arterial oxygen saturations via 
CO-oximetry, would be needed in order to ascertain its accuracy in the measurement 
of oxygen saturation. Again, longer term monitoring periods, for example in the 
intensive care setting, would be useful in order to evaluate its use over a longer time 
period as well as to assess its robustness for use as part of additional monitoring in an 
intensive care setting. 
 
The potential for use in continuously monitoring oxygen saturation in patients using 
the oesophagus as a site is enormous. The possible advantages it would have over the 
commercially available finger pulse oximetry is that of:  
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a) almost instantaneous readings with no lag time compared with a conventional 
pulse oximeter. 
b) independent of peripheral perfusion or the assumption of viable digits to use 
as monitoring sites. For example in patients who have been affected by severe 
burns or have had limb amputations. Whilst the probe would be most 
comfortably tolerated in the sedated patient; newer, less invasive probes 
could be developed that rest in the upper airway that may be better tolerated. 
It has to be borne in mind that frequently, nasogastric tubes of the same size 
are put down the nose and into the oesophagus and hence stomach of awake 
patients, whilst in hospital for purposes such as feeding or gastric emptying. 
 
In the last described study, an evaluation of a fibreoptic probe used to measure 
oxygen saturation in splanchnic organs was undertaken. A total of 20 patients were 
recruited to this study. 17 out of the 20 patients recruited had results that were 
suitably sufficient for analysis. The strength of this study was that the probe was 
constructed in such a way that it could be used interchangeably to measure PPG 
signals from any body cavity. It could be used in any open area in the abdomen that 
the operating surgeon has access to; all that was needed was a sterile plastic sheath in 
which to enclose the probe. There were good quality signals obtained from all the 
splanchnic sites under investigation. There was also a very good correlation with the 
readings taken from the peripheral commercial finger pulse oximeter. The signals 
obtained were again prone to interference from movement artefacts and would have 
very likely been affected by surgical diathermy as well if this had been on during the 
time of the recordings. In the clinical situation, if there were any clinical concerns 
about arterial oxygenation, and hence perfusion of vital organs, any monitoring 
period would have been absent from the effects of diathermy to allow the best 
possible readings to be taken. Whilst there was a close trend seen with the readings 
taken from standard pulse oximetry, there were no comparisons in this pilot study 
with measurements from arterial CO-oximetry.  
 
The success of these pilot studies looking at the use of a fibreoptic probe to give 
almost instantaneous readings, which can be translated into clinically meaningful 
readings, will form the basis of more research into the area and further development 
of such probes on the medical engineering front. The scope for the use of fibreoptic 
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technology to measure oxygen saturation in tissues can be applied to most body 
cavities. The potential usefulness to be able to measure brain oxygen saturation, 
offering a novel tool for the monitoring of patients with brain pathology has the 
potential to contribute to the way we can monitor patients with head injuries. In 
addition, with further development, it is entirely feasible that other functions such as 
electrolytes, glucose measurements and so on could be achieved using this 
technology. 
 
The development of a fibreoptic probe that could measure one and perhaps even 
more modalities in addition to oxygen saturation- such as carbon dioxide tension, 
glucose and other metabolites could have a significant impact on the way patients 
with brain pathology may be monitored in the years to come. It was shown that the 
fibreoptic probe could obtain good signals over a short period in a patient who had an 
ICP bolt in situ. The challenge would be in recruiting and evaluating how long the 
probe can remain in situ for, over a more extended period of time, in patients with 
brain pathology. Ideally, it should be able to remain in situ until the ICP bolt is no 
longer needed. 
 
There is potential benefit for decision support and patient management that may be 
derived from being able to monitor oxygen saturation regionally and/or directly from 
tissues. Clinically meaningful signals, obtained from placing the probe on or in intra-
abdominal organs such as the liver, stomach, large and small bowels, could have 
implications in clinical practice, if this is successfully validated in bigger studies. 
This could be a useful tool for the operating surgeon by indicating the perfusion of 
internal organs, which could be affected by surgical procedures such as bowel 
resections or reconstructive surgery.    
 
Conclusions 
 
These studies show that we can obtain good quality, viable PPG signals using 
fibreoptic technology. The studies also demonstrated that PPG signals could be 
obtained from numerous locations in the body and could have potential in the future 
for different monitoring modalities. For example, future developments would be to 
measure other variables such as arterial-venous oxygen differences in order to assess 
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oxygen uptake and utilisation. (104)(105)(106) Other uses could be in monitoring 
free-flap perfusion in reconstructive surgery. (107) 
 
These were all pilot studies evaluating the use of specifically designed probes in the 
clinical setting. The number of patients targeted for each study was appropriate for a 
pilot project; however there were unforeseen constraints with recruitment of patients 
for the intracranial monitoring studies for different reasons. One was logistical in 
terms of availability of neurosurgical patients we could recruit from; the second, 
which contributed to a significant amount of research time being wasted was on 
getting agreement from the newly outsourced clinical sterilisation services to sterilise 
the fibreoptic probes for research purposes. The primary objectives in all the studies 
of obtaining good PPG signals and correlation with traditional pulse oximetry was 
successfully achieved. Ideally, comparison with blood co-oximetry would have been 
interesting but this would have required insertion of invasive arterial lines in all 
patients, most of whom would not have required one as part of their routine care. 
Some problems with obtaining measurements included movement artefacts, both 
from the surgeons as well as the operator holding the fibreoptic device. Interference 
from surgical diathermy, which is difficult to avoid in a theatre environment, was a 
significant problem, which needs to be taken into account when designing future 
probes. A filter to block the effects from diathermy would need to be incorporated. 
There are limitations to any readings of oxygen saturation whether using 
conventional or more novel methods such as the ones described above. The 
advantage of using optical technology is the potential to monitor tissue oxygenation 
in regions of the body not accessed before by other methods, this could include not 
only arterial saturation, but venous saturation; any results should be looked at in 
conjunction with other methods, assimilating other parameters such as blood test 
results, metabolic states and overall well being of the patient. (108) These studies 
focussed on measurement of arterial oxygen saturation, which is of course distinct 
from ‘tissue oxygenation’. Note that tissue oxygenation can refer to the partial 
pressure of oxygen in the extracellular fluid as measured by a Clark electrode, or in 
the case of near infrared spectroscopy, can refer to the overall oxygen saturation of 
the blood in arteries, veins and capillaries (‘Tissue Oxygenation Index’) (109). 
Normal arterial oxygen saturation measured in a specific tissue may indicate the 
presence of adequate delivery of oxygenated blood, but does not reflect the actual 
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oxygen utilisation, or the balance between the oxygen supply and the metabolic 
demand.  As such, the measurements documented in this research should be 
evaluated in combination with other measurements such as tissue oxygenation pO2 
and/or Tissue Oxygenation Index in a future investigation.  Ultimately readings used 
in the clinical setting should be interpreted in the context of other measurements as 
well as patients’ underlying conditions, in order to support decisions regarding 
clinical interventions. I believe that future direction with monitoring oxygenation in 
the clinical setting would have to involve an integration of these different techniques 
and modalities in looking at oxygen flux in the body, so as to give a balanced and 
accurate picture of the physiological status of the patient. 
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APPENDIX A 
A.1 Protocol for oxygen saturation measurements on ITU 
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Evaluation of a new method of measuring cerebral oxygen saturation in ITU patients 
via a cranial bolt. 
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CONFIDENTIAL: Further dissemination of this protocol may only be made with the 
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1. Title 
 Evaluation of a new method of measuring cerebral oxygen saturation in ITU 
patients via a cranial bolt. 
 
 
2. Investigators 
 
2.1 Principal Investigator 
 
Prof Richard M Langford,  
Director, Anaesthetic Laboratory, St Bartholomew’s Hospital (SBH). 
 
 
2.2 Other Investigators 
 
Mr Justin Phillips, Principal Technologist, Anaesthetic Laboratory, SBH. 
Dr Serene Chang, Clinical Lecturer, Anaesthetic Laboratory, SBH. 
Dr Kishore Maney, Research Fellow, Anaesthetic Laboratory, SBH. 
 
 
3. Aim 
 
To establish proof of concept of a technique to facilitate measurement of cerebral 
oxygen saturation in patients recovering from head injuries and neurosurgery in 
whom cranial bolts are indicated as part of their routine care. 
 
The study will: 
• Enable us to find out whether it is possible to measure pulsatile 
photoplethysmograph(PPG) signals and oxygen saturation (SpO2) directly 
from the brain tissue. 
• Compare SpO2 readings from the brain with measurements from a near-
infrared spectroscopy (NIRS) system, a finger pulse oximeter and the 
patient’s blood gas analysis results,  
• Attempt to correlate changes in the PPG signal strength and SaO2 readings 
with measured changes in cerebral perfusion pressure (CPP).    
• Determine whether the brain tissue SpO2 is a reliable indicator of cerebral 
wellbeing. 
 
 
4. Background and Introduction 
 
In some high-risk patients (such as those recovering from severe head injury or 
neurosurgery) secondary brain damage, caused by neuronal ischaemia and/or 
hypoxia is a common and potentially preventable cause of mortality and residual 
disability [1]-[2].  Secondary brain injury is associated with inadequate cerebral 
perfusion caused by hypotension, raised intracranial pressure, cerebral 
vasospasm/loss of CBF autoregulation, and/or traumatic arterial/venous disruption 
[3]. 
 
Near Infrared Spectroscopy (NIRS) is currently used to monitor the adequacy of 
cerebral perfusion by estimating Hb saturation.  The accuracy of NIRS is 
compromised by attenuation and modulation of light by superficial tissues (e.g. skull, 
scalp) [4].  As non-invasive solutions have not succeeded fully in measuring brain 
oxygen levels [5], our developments have focused on probes that are positioned on 
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or in the brain via a hollow bolt screwed into the skull.  We have developed a system 
based on pulse oximeter technology whereby oxygen saturation is calculated by 
measuring the relative absorption of two wavelengths of light by haemoglobin in the 
cells.  The contribution to the total absorption of light by the arterial blood 
component is calculated by detecting the pulsatile PPG signal for each of the two 
wavelengths. 
 
Unlike current commercially available oximeters, which utilise external sensors, 
transmitting light through skin, bone and other tissue, the optical fibre system 
provides a means of directly accessing the cerebral tissue.  The system meets the 
clinical need of rapid accurate regional measurement of brain oxygen content 
reducing the chance of secondary brain damage, or death to the patient.  Our group 
already has considerable experience in developing and validating miniaturised 
oximetry devices [6]. A fibreoptic device is the next logical step in this research 
programme. 
 
 
5. Patients 
 
5.1 Recruiting 
 
We aim to recruit patients for the study, who require cranial bolts as part of their 
routine neurosurgical/intensive care. These will be consenting competent pre-
operative neurosurgery patients, and the unconscious head injured patients, for 
whom a relative’s assent will be sought.   
 
We aim to recruit up to 20 patients. 
 
 
5.2 Inclusion Criteria 
 
• Patients scheduled for neurosurgery who require monitoring via an 
intracranial bolt. 
• Patients who having suffered head injury/medical conditions who require 
monitoring via an intracranial bolt. 
 
 
5.3 Exclusion Criteria 
 
• Patients in whom more extensive intracranial monitoring is required ( e.g 
brain tissue oxygen partial pressure and/or brain temperature monitoring). In 
these cases, two or three lumens of the cranial bolt will be required so the 
lumens will not be free for the optical probe. 
• Patients who decline consent. 
• Relatives of patients who decline assent. 
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6. Materials and Methods 
 
6.1 Instrumentation 
 
The probe is based on a pair of optical fibres and is designed to utilise two of the 
three channels of the LiCox IM3 Cranial Access System.  This system is already 
routinely used for monitoring intracranial pressure and other parameters in post-
operative neurosurgical patients and patients suffering from head injuries. The fibres 
are approved for medical use, are of biocompatible materials and will be supplied 
sterile. 
 
The fibres will be connected to a box containing two (red and infrared) light sources, 
a photodetector, power supplies (two 12 V lead acid batteries), a circuit board and a 
computer interface. A block diagram of the system is shown in Figure 1. The circuit 
board performs the following functions: 
• switching the light sources on and off 
• amplification of the detected light intensity signals 
• filtering the signals to remove interference 
• separation of pulsatile (ac) signals from non-pulsatile (dc) signals 
• synchronisation of computer data acqusition with light source timing. 
 
The instrument box is connected to an analogue-to-digital converter (National 
Instruments Inc., Austin, TX, USA) installed in the PCMCIA slot of a notebook 
computer. 
 
 
 
Figure 1: Block diagram of the PPG measurement system 
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6.2 Method 
 
The clinical investigator will identify neurosurgical patients admitted to The Royal 
London Hospital for intensive care management of head injury, who require a cranial 
LiCox bolt and also pre-operative neurosurgical patients who require a cranial LiCox 
bolt. The emergency admission patients on the intensive care unit will be 
unconscious, and hence the investigator will approach the patient’s relative for 
written assent. The pre-operative patients able to give informed consent will be 
approached by the investigator for written consent.  
 
Patients in the ITU who have been recruited for the study will have bolts already 
inserted as part of their neurosurgical management.  A clinician will insert the optical 
fibres into the bolt under sterile conditions.  The fibres will be advanced until a good 
signal is obtained or any unexpected resistance is encountered.  The fibres will  
penetrate 1-2cm into the brain tissue, as in the case with existing devices used with 
the LiCox bolts.   
 
The placing of the optical fibre probe will be abandoned if there is any difficulty 
inserting the optical fibres into the cranial bolt or if requested to desist by any of the 
responsible clinical staff: the ITU clinicians, nurses or neurosurgeon/neurologist in 
charge of the patient’s care. The fibres are locked with a self-sealing cap to prevent 
contamination and infection. At the beginning of the measurement period, a pair of 
NIRS probes will be placed on the forehead. Measurements will be recorded from 
the optical fibre system, the NIRS system and routine monitoring until the fibres are 
removed en bloc with the cranial bolt.   
 
6.3 Measurements 
 
Red and Infrared PPG and dc signals, calculated cerebral arterial oxygen saturation, 
calculated cerebral tissue oxygen saturation, cerebral oxygen saturation from an 
NIRS system, arterial oxygen saturation from a finger probe, intracranial pressure 
(ICP) and arterial blood pressure and derived cerebral perfusion pressure will be 
recorded. 
 
 
7. Conduct and Monitoring 
 
The study will be conducted according to ICH/GCP standards. The prinicipal 
investigator and members of the study research group will be responsible for 
monitoring the conduct of the study. The sponsor, Queen Mary University of 
London, may audit the study. 
 
 
8. Data Analysis 
 
The quality of acquired signals will be evaluated. The data will be stored on a 
password protected computer in a locked office up to a maximum period of 15 
years. Only members of the research group will have access to the data. The 
analysis of data will take place at the Anaesthetic Laboratory, St Bartholomew’s 
Hospital. 
 
As this is a proof of concept study, the aim is to establish that reliable signals can be 
obtained using the fibre optic oximetry probe. At this stage in the development of the 
device, the present study is not intended to demonstrate the potential for medical 
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decision support. We are however planning to obtain preliminary comparative data 
in a pilot to justify a larger clinical evaluation study. 
 
 
9. Reports of Study Results and Publication 
 
It is intended to present the results of the study at a scientific meeting and publish in 
a peer-reviewed journal. 
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A.2 Protocol for oxygen saturation measurements in the oesophagus 
 
 
 
 
 
 
 
 
 
   
 
Protocol 
 
Evaluation of a new method of measuring oesophageal oxygen saturation in 
anaesthetised patients using a fibreoptic probe 
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1. Title 
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A new method for measuring oesophageal oxygen saturation in anaesthetised 
patients 
 
2. Investigators 
 
2.1 Principal Investigator  
Professor Richard M Langford 
Director Anaesthetic Laboratory, St Bartholomew’s Hospital (SBH). 
 
2.2 Other Investigators 
Mr Justin Phillips, Principal Technologist, Anaesthetic Laboratory, SBH. 
Dr Serene Chang, Clinical Lecturer, Anaesthetic Laboratory, SBH. 
Dr Kishore Maney, Research Fellow, SBH 
Dr Panicos Kyriacou, Honorary Research Fellow, SBH. 
 
3. Aim 
 
To evaluate whether a newly developed oesophageal pulse oximeter probe based 
on optical fibre technology can provide meaningful and reliable signals from which 
useful patient monitoring measurements can be derived. 
 
4. Background and Introduction 
 
Pulse oximetry is widely used in anaesthesia and intensive care monitoring. It is a 
valuable, non-invasive optical monitoring technique used for continuous 
measurement of arterial blood oxygen saturation (SpO2). In the late 1980s, pulse 
oximetry became the mandated standard for monitoring during anaesthesia. 
Although pulse oximeters generally give reliable readings of blood oxygen 
saturation, there are significant limitations on the accuracy and availability of pulse 
oximeter data in some circumstances. When peripheral perfusion is poor, as in 
states of hypovolaemia, hypothermia, vasoconstriction, low cardiac output and low 
mean arterial pressure, oxygenation readings become extremely unreliable or 
cease. To overcome the limitations of  current commercial pulse oximeters where 
peripheral perfusion is compromised, we have developed miniaturised sensors that 
allowed the monitoring of SpO2 values at more central parts of the body such as the 
oesophagus, on the hypothesis that adequate perfusion at these sites will be 
preserved, compared with the periphery [1]-[2]. Our studies have shown that 
measurable photoplethysmographic (PPG) signals and SpO2 values can be 
detected in the oesophagus of healthy patients during anaesthesia and from 
patients undergoing cardiothoracic surgery [3]. The PPG signal is a potentially 
valuable indicator of both oesophageal perfusion and also general well-being. 
Following our experience in developing and validating miniaturised SpO2 devices, 
the next logical step is the development of a fibreoptic device. The probe would be 
smaller, completely biocompatible and sterilisable and confer the added safety 
benefit of complete electrical isolation. 
 
This proof-of-concept study will enable us to:  
1) measure oesophageal oxygen saturation (SpO2). 
2) compare this with simultaneous readings from a finger pulse oximeter. 
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5. Patients 
 
5.1 Recruiting 
 
The patients will be recruited with their full consent as early as possible. This will be 
done either in the pre-operative assessment clinics or when they arrive in hospital 
the day before or early in the morning of their scheduled surgery.  
 
5.2 Inclusion criteria 
 
Adult patients aged (18-70) from whom full written informed consent will be sought. 
Patients undergoing routine surgery who require a general anaesthetic including 
tracheal intubation as part of their anaesthetic. 
Patients who fall into the American Society of Anesthesiologists scoring system of 
ASA I-III. 
Patients with no known clotting abnormalities. 
Patients who have no upper airway problems, or anticipated difficulty with intubation. 
Patients with have not had previous major head and neck surgery. 
Patients without a anatomical abnormalities of the upper airways or upper gastro-
oesophageal tract. 
Patients without a history of gastro-oesophageal reflux disease, hiatus hernia or 
previous oesophageal surgery. 
 
5.3 Exclusion criteria 
 
Patients who decline consent. 
Patients with a known clotting abnormality. 
Patients with an abnormal anatomy of the upper airways or upper gastrointestinal 
tract. 
Patients with a history of gastro-oesophageal reflux disease or a hiatus hernia. 
Patients with a history of oesophageal varices. 
Patients with known oesophageal pathology or previous surgery to the oesophagus 
or stomach. 
Patients who are an anticipated difficult intubation. 
Pregnant women. 
  
 
 
 
6. Materials and Methods 
 
6.1 Instrumentation 
An oesophageal probe has been developed which comprises a cylindrical epoxy 
moulding in which two optical fibres are embedded as shown in Figure 1.  The probe 
will be inserted into a clean, sealed naso-gastric tube prior to insertion. The fibres 
are approved for medical use and are constructed from biocompatible materials. 
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Figure 1: Oesophageal oximetry probe 
 
The proximal end of the fibres will be connected to a box containing two (red and 
infrared) light sources, a photodetector, power supplies (two 12 V lead acid 
batteries), a circuit board and a computer interface. A block diagram of the system is 
shown in Figure 2. The circuit board performs the following functions: 
• switching the light sources on and off 
• amplification of the detected light intensity signals 
• filtering the signals to remove interference 
• separation of pulsatile (ac) signals from non-pulsatile (dc) signals 
• synchronisation of computer data acquisition with light source timing. 
 
The instrument box is connected to a data acquisition card (National Instruments 
Inc., Austin, TX, USA) installed in the PCMCIA slot of a notebook computer. 
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Figure 2 : Block diagram of the PPG measurement system 
 
 
6.2 Method 
 
The investigators will seek full written informed consent from the appropriate 
patients as early as possible before their scheduled surgery. A written information 
sheet will be provided. The surgeons, anaesthetists and theatre staff involved in the 
care of the patient will also be informed of the study and patients will only be 
recruited with their agreement to proceed with the study. We aim to recruit up to 20 
patients.  
 
Adult patients aged (18-70) and deemed ‘low risk’ by the American Society of 
Anesthesiologists score of  (I-III) will be identified from the elective operating lists at 
Barts and The London NHS trust. Any patients in whom difficulty or increased risk of  
probe placement is anticipated, as listed by our exclusion criteria, will be excluded. 
Similarly, the research procedure will be abandoned if there is any difficulty with the 
anaesthesia or visualisation of the gullet or resistance to passage of the probe.  
After induction of anaesthesia and immediately after tracheal intubation, the probe 
will be inserted into the gullet by the anaesthetist, via the patient’s mouth, under 
direct vision with a laryngoscope and Magill’s forceps so the tip is at a distance of 35 
cm measured from the teeth.  Once the probe is in position, the light sources will be 
switched on and signals recorded for one minute. The probe will then be withdrawn 
5 cm at a time and signals recorded at each position until the probe is at a depth of 
15 cm.  The arterial oxygen saturation will be calculated continuously from the 
measured signals and recorded. This will be compared to peripheral pulse oximeter 
readings.  The probe will then be advanced to the position which yielded signals of 
greatest amplitude and left in place while the surgery commences, during which time 
signals will be recorded continuously on the notebook computer. The arterial oxygen 
saturation will be calculated continuously from the measured signals and recorded. 
This will be compared to peripheral pulse oximeter readings.  The probe will be left 
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in position for a total period of not less than 10 minutes and not exceeding 60 
minutes.  The probe will be removed at the end of the measurement period, before 
the patient is woken up. We plan to review each patient post-operatively, and will 
take this opportunity to both thank the patient for their participation and let them 
know if we were successful in obtaining potentially useful pulse wave signals. 
 
6.3 Measurements 
 
Red and infrared PPG and dc signals from the oesophagus, calculated arterial 
oxygen saturation and arterial oxygen saturation from a finger probe will be 
measured. 
 
7. Conduct and Monitoring 
 
The Chief Investigator and members of the research group will be responsible for 
monitoring the conduct of the study. The sponsor, Barts and The London NHS Trust, 
may audit the study. 
 
 
8. Data Analysis 
 
All data will be stored in a password protected computer in a locked office. All study 
data will be stored in a custom made password protected database which identifies 
the patient only by initials and a study number. Only members from the research 
group will have access to and perform the data analysis. This will take place at the 
Anaesthetic Laboratory, St Bartholomew’s Hospital.  Data will be stored for a 
maximum of 15 years and will be subject to internal review.  
 
The quality of acquired signals will be evaluated. As this is a proof of concept study, 
the aim is to establish that reliable signals can be obtained using the fibreoptic 
oximetry probe. At this stage in the development of the device, the present study is 
not intended to demonstrate the potential for medical decision support. We are 
however planning to obtain preliminary comparative data in a pilot to justify a larger 
clinical evaluation study. 
 
 
9. Reports of Study Results and Publication 
 
The results of the study will be evaluated and publication of the results in a peer-
reviewed journal is planned. 
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A.3 Protocol for oxygen saturation measurements in the abdominal cavity 
 
 
 
 
 
 
 
 
Protocol 
 
Title: 
Evaluation of a new method of measuring arterial pulsation and oxygen saturation 
from the surface of abdominal visceral organs using a fibreoptic probe 
 
Version: 2 
Dated: 12th December 2006  
 
 
 
 
 
Protocol Approval 
 
 
Principal Investigator: Prof Richard M Langford 
 
Signed: ____________________ 
 
Date:  _____________________ 
 
 
 
 
 
 
 
CONFIDENTIAL: Further dissemination of this protocol may only be made with 
the permission of the Principal Investigator 
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1. Title: Evaluation of a new method of measuring arterial pulsation and oxygen 
saturation from surfaces of abdominal organs during laparotomy.  
 
2. Investigators: 
 
2.1 Principal Investigator  
 
Professor Richard M Langford 
Director Anaesthetic Laboratory, Barts and the London NHS Trust (BLT) 
 
2.2 Other Investigators 
 
Dr Kishore Maney, Research Fellow, BLT. 
Dr Serene Chang, Clinical Lecturer, Anaesthetic Laboratory, BLT. 
Ms Michelle Hickey, Honorary Research Fellow, BLT  
Dr Panicos Kyriacou, Honorary Research Fellow, BLT. 
Mr Justin Phillips, Principal Technologist, Anaesthetic Laboratory, BLT. 
 
 
3. Aim 
 
3.1 Primary Aim:  
 
Proof of concept study to evaluate a newly developed fibreoptic pulse oximeter probe 
used to monitoring arterial pulsation and oxygen saturation from the abdominal visceral 
organs surfaces.   
 
It is hoped that this can provide meaningful and reliable signals, which could provide the 
basis for development of a miniature monitoring probe for a larger evaluation study. 
 
 
 
3.2 Secondary Aims  
 
To compare the measurements  photoplethysmographic(PPG) signals derived from the 
new pulse oximeter probe placed on various sites on the abdominal organs with the 
PPG  signals acquired from the finger probe.  
 
We will try to correlate PPG signals with ECG signals.  
 
4.Background and Introduction 
 
Pulse oximetry is widely used in anaesthesia and intensive care monitoring. It is a 
valuable, non-invasive optical monitoring technique used for continuous measurement 
of arterial blood oxygen saturation (SpO2). In the late 1980s, pulse oximetry became 
the mandated standard for monitoring during anaesthesia.  
 
Our previous studies have shown that measurable photoplethysmographic (PPG) 
signals and SpO2 values can be detected in the oesophagus of healthy patients during 
anaesthesia and in intensive care following cardiothoracic surgery [1,4,5]. Hence, an 
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intra-abdominal monitoring probe may prove to be a simple and potentially valuable 
continuous indicator of abdominal organ perfusion.  
 
The study will enable us to:  
1. Measure oxygen saturation (SpO2) of the abdominal organs. 
2. Compare the measured oxygen saturation from the surface of abdominal organs 
with a finger probe (using the same fibreoptic technology) and commercially 
available finger pulse oximeter probes. 
 
5. Patients 
 
5.1 Recruiting 
This is a proof of concept study and will be observational in design. The study will be 
conducted according to ICH/GCP standards. The patients will be recruited with their full 
consent as early as possible. This will be done either in pre-operative assessment 
clinics or when they arrive into hospital the day before their scheduled surgery.  
 
5.2 Inclusion criteria 
 
A. Adult patients undergoing elective laparotomy. 
B. Adult patients from whom full written informed consent will be sought. 
 
5.3 Exclusion criteria 
 
A. Patients who decline consent. 
B. Patients undergoing emergency surgery. 
 
6. Materials and Methods 
 
6.1 Instrumentation 
 
A fibreoptic sensor for measuring oxygen levels in arterial blood in various abdominal 
organs (gut, liver, kidney) has been constructed. The probe consists of two fibreoptic 
leads. One is used to shine light at the tissue of interest and the other to bring any light 
back that is reflected from the surface of the abdominal organs. The fibres are 
connected to a processing system (electronic circuit board enclosed in a box). The 
circuit board comprises all optical components (light sources and photo detector) and 
electronic circuits used to drive the light sources and process the incoming signal from 
the tissue via a fibre. The processing system is battery operated (two 9V PP3 batteries). 
The abdominal pulse signals are sent to a computer. Software was written to display on 
the screen of the computer all the signals coming from the patient. A simple block 
diagram of the system is shown in Figure 1.The end of the probe is embedded in epoxy 
and it looks like a pencil type probe. Such geometry will allow the medical investigator 
or surgeon to have a good handle of the probe. Also the probe is inserted into a sterile 
plastic sleeve before use to make measurements on a patient. 
An identical probe, like the one described above has been developed to measure the 
oxygen level in blood at the finger (Figure 2). The reason for two identical probes 
measuring oxygen levels in blood at two different locations is for comparison purposes. 
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Figure 1 
 
 
Figure 2 
 
A Lead II ECG channel is also included in the overall system to monitor the R waves, 
which are used as a timing reference for the splanchnic and finger PPG signals. 
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Red and infrared PPG signals, red and infrared DC signals and ECG signals are 
digitised at a rate of 200Hz by the National Instruments data acquisition card which is 
connected to a Toshiba laptop computer. These signals are then further processed 
using LabVIEW. LabVIEW (Laboratory Virtual Instrument Engineering Workbench) is a 
programme development environment that utilises a graphical programming language, 
G, to create programmes in block diagram form. It relies on graphical symbols, rather 
than textual language (C, C++, Java) to describe programming actions. It is especially 
suitable for instrument control, data acquisition, and pre/post processing of acquired 
data. LabVIEW programmes are called Virtual Instruments (VIs) because their 
appearance and operation imitate actual instruments (see Figure 3).  
 
 
 
Figure 3 Front panel of virtual instrument showing the display. 
 
The acquired signals are filtered to remove any digitisation noise and displayed on the 
front panel of the virtual instrument (See Figure 3).  Finally, the signals are grouped 
together, converted into spreadsheet format and saved to a text file for post-analysis.  
 
To minimise the risk to the patient from the electrical hazard associated with the 
accidental or unintended mains power up of the laptop computer, electrical isolation 
techniques were incorporated into the processing system.  
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6.2 Method 
 
Adult patients who are about to undergo elective abdominal (laparotomy) surgery will be 
identified from the elective operating lists at Barts and The London NHS trust. The 
investigators will seek full written informed consent from the appropriate patients as 
early as possible before their scheduled surgery. A written information sheet will be 
provided. The surgeons, anaesthetists and theatre staff involved in the care of the 
patient will be informed of the study and patients will only be recruited with their 
agreement to proceed with the study. We aim to recruit up to 20 patients. 
 
We intend to record all analogous data output from the routine monitoring equipment 
used intra-operatively in theatres by interfacing the monitors into the notebook 
computer if possible. If this is not possible then the ECG is recorded using additional set 
of ECG leads and recorder and a separate finger pulse oximeter which could be easily 
synchronised with PPG signals in the notebook computer. 
 
6.3 Measurements 
 
Red and infrared PPG and dc signals from the surfaces of the organs, calculated 
arterial oxygen saturation from the organs and arterial oxygen saturation from a finger 
probe, as well as ECG will be measured and recorded in a notebook computer. 
 
7. Conduct and Monitoring 
 
The principal investigator and members of the research group will be responsible for 
monitoring the conduct of the study. The sponsor, Barts and The London NHS Trust, 
may audit the study. 
 
8. Data Analysis 
 
All data will be stored in a password protected computer in a locked office. All study 
data will be stored in a custom made password protected database which identifies the 
patient only by a study number. Only members from the research group will have 
access to and perform the data analysis. This will take place at the Anaesthetic 
Laboratory, St Bartholomew’s Hospital.  Data will be stored for a maximum of 15 years 
and will be subject to internal review.  
 
The quality of acquired signals will be evaluated. As this is a proof of concept study, the 
aim is to establish that reliable signals can be obtained using the probe. At this stage in 
the development of the device, the present study is not intended to demonstrate the 
potential for medical decision support. We are however planning to obtain preliminary 
comparative data in a pilot to justify a larger clinical evaluation study. 
 
 
9. Reports of Study Results and Publication 
 
The results of the study will be evaluated and publication of the results in a peer-
reviewed journal is planned. 
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